rfhg_130201.1

Basic information about the TSS

---

TSS ID: rfhg_130201.1 Species: human Chr: chr10		Start: 110871790 End: 110871800 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2391081,EH38E1499373)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000393104.6:0 GeneID: 27250 HGNC/MGI_ID: HGNC:8763 UniProt_ID: Q53EL6 Nearer transcript ids and distances: ENST00000467574.5:93 AK312540:99 AK315295:118 ENST00000483670.5:119 ENST00000280154.12:128 NM_001199492.2:128 NM_014456.5:128 NM_145341.4:128 AK296753:128 AK223623:128 BC026104:131 BC031049:131 BC015036:141 ENST00000444997.1:155 U96628:197 view more...

Gene_name: programmed cell death 4 Gene_symbol: PDCD4 Gene_synonyms: H731 Gene_source: HGNC:8763

TATA-Box annotation

---

Distance to TSS:	0
Nearest PromoterID:	NM_001199492
Entrez ID:	27250
Nearest Unigene:	Hs.711490
Nearest Refseq:	NM_014456
Nearest Ensembl:	ENSG00000150593
Gene Name:	programmed cell death 4
Gene Alias:	H731
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.454545
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@PDCD4 p2@PDCD4 p3@PDCD4 p4@PDCD4 p5@PDCD4 p6@PDCD4 p7@PDCD4 p10@PDCD4
Sample		p1@PDCD4	p2@PDCD4	p3@PDCD4	p4@PDCD4	p5@PDCD4	p6@PDCD4	p7@PDCD4	p10@PDCD4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	52.79	4.29	0.58	6.82	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	49.37	5.26	0.40	6.47	0.00	0.40	0.40	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	62.50	5.98	0.39	7.33	0.00	0.00	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	50.73	5.20	0.42	6.03	0.00	0.00	0.62	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	58.72	5.40	0.45	5.40	0.22	0.00	0.45	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	65.51	5.81	0.00	4.46	0.00	0.19	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	54.25	4.36	0.44	2.83	0.22	0.44	0.65	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	49.66	1.21	0.73	3.88	0.24	0.00	0.97	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	44.24	5.34	0.00	4.49	0.00	0.00	0.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	65.50	4.06	0.58	5.80	0.00	0.58	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	49.72	6.87	0.00	4.04	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	62.20	4.88	0.00	5.29	0.41	0.00	0.00	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	22.89	3.06	4.51	0.48	0.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	20.60	1.05	3.76	0.45	0.90	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	19.32	1.98	3.29	0.22	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	18.61	0.75	3.02	0.25	0.75	0.00	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	16.38	1.31	2.84	0.00	0.66	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	17.72	4.22	2.11	0.00	0.42	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.99	2.13	2.13	0.00	0.00	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	17.75	1.20	3.01	0.15	0.60	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	19.78	2.00	3.88	0.40	0.67	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	18.64	1.21	4.83	0.35	0.17	0.00	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	16.54	1.55	3.36	0.52	0.39	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	16.74	2.43	3.40	0.24	0.49	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	18.32	2.06	3.87	0.26	0.52	0.00	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	18.67	2.53	3.80	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	22.53	1.65	2.20	0.00	0.55	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	18.39	1.18	4.95	0.00	0.47	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	15.18	1.29	3.55	0.32	0.81	0.16	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	17.37	1.99	3.26	0.54	0.18	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	17.17	1.67	2.09	0.21	0.84	0.00	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	12.31	0.78	2.93	0.00	0.39	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	16.46	1.90	2.32	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	19.63	2.31	2.31	0.16	0.82	0.00	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	16.64	1.87	1.50	0.19	0.56	0.00	0.37	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	10.73	1.34	1.92	0.38	0.38	0.00	0.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	15.74	2.45	2.04	0.00	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	15.72	0.60	1.81	0.00	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	18.37	0.54	2.97	0.00	0.27	0.00	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.92	1.20	2.40	0.24	0.72	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	15.76	1.88	2.12	0.94	0.24	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	13.32	1.46	1.90	0.59	0.73	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	10.97	1.27	1.48	0.21	0.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	11.54	1.40	3.50	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	14.46	1.20	2.81	0.20	0.20	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	14.42	1.16	2.09	0.70	1.40	0.00	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	11.76	1.20	0.48	0.24	0.96	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	12.52	0.89	4.77	0.30	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.01	0.48	2.15	0.48	0.72	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	11.53	1.21	2.02	0.20	1.01	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	13.53	1.02	1.43	0.41	0.61	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	14.23	1.33	3.78	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	209.88	69.96	83.95	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	8.16	1.06	3.90	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	7.29	0.99	1.33	0.66	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	47.82	1.68	4.19	3.36	0.84	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.07	2.30	4.13	0.92	0.92	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.70	0.65	1.62	0.32	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	8.35	0.64	1.93	0.64	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	18.23	2.20	3.14	0.00	0.63	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	6.35	0.71	1.41	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	3.93	0.56	1.12	0.56	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	24.68	3.98	1.59	0.00	0.80	0.00	1.59	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	14.61	1.36	2.72	1.02	0.34	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	8.77	0.97	2.27	0.32	0.32	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	8.52	1.06	1.77	0.35	0.35	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	274.79	96.98	48.49	0.00	16.16	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	213.23	39.49	31.59	0.00	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	7.80	0.49	0.49	0.49	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	8.43	0.99	0.50	0.50	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	10.32	0.94	1.41	0.00	0.00	0.00	0.47	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	11.92	0.66	2.65	0.33	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	3.40	1.24	0.93	0.31	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	7.03	0.92	1.22	0.00	0.31	0.00	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	38.17	4.91	1.43	0.95	0.16	0.16	0.32	0.32
Adipocyte - breast, donor2	11327-117E4	33.53	6.10	0.80	1.44	0.32	0.48	0.96	0.48
Adipocyte - omental, donor1	11473-119C6	49.75	5.09	2.67	1.53	0.38	0.25	0.25	0.38
Adipocyte - omental, donor2	11474-119C7	23.92	4.48	0.00	0.75	1.49	0.00	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	31.48	5.69	0.00	0.67	0.00	0.00	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	18.50	2.55	0.00	0.00	0.00	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	1.10	2.20	2.20	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	37.03	2.71	0.45	0.00	0.00	0.00	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	36.67	5.56	1.04	1.91	0.35	0.17	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	65.52	8.02	5.67	1.17	0.59	0.00	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	37.58	6.43	2.83	0.51	0.26	0.26	0.77	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	47.67	5.58	3.35	0.56	0.00	0.28	0.00	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	72.30	5.29	3.53	0.59	0.00	0.00	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	88.15	6.11	3.62	3.46	0.48	0.97	0.08	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	69.39	10.33	2.58	1.61	0.32	0.32	1.29	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	44.25	3.73	1.60	1.60	0.53	0.53	1.07	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	51.19	7.79	1.11	1.11	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	40.34	4.16	0.83	0.00	0.00	0.42	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	47.22	8.29	2.26	0.75	0.75	0.00	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	52.69	5.89	2.29	0.65	0.33	0.65	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	63.63	9.44	4.57	1.83	0.91	1.52	0.30	1.22
Alveolar Epithelial Cells, donor1	11510-119G7	5.30	0.44	0.66	0.66	0.22	0.00	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	3.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	3.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	14.75	1.08	1.08	0.54	0.00	0.00	0.54	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	1.67	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	16.44	2.26	0.82	0.41	0.21	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	73.35	10.41	4.12	1.83	1.26	0.00	0.23	0.00
Anulus Pulposus Cell, donor2	11463-119B5	60.00	9.31	1.22	3.43	0.24	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	31.45	10.78	2.70	1.35	0.00	0.00	2.25	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	28.65	13.46	0.43	0.87	0.87	0.00	1.74	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	29.96	12.84	2.14	2.14	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	34.38	5.98	0.30	0.90	0.90	0.00	0.60	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	31.62	2.53	2.53	2.53	1.26	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	16.50	4.62	0.66	0.00	0.66	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	29.56	8.45	0.65	0.97	0.32	0.00	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	25.73	8.74	1.46	1.46	1.46	0.00	1.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	23.16	6.53	1.78	0.59	0.59	0.00	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	24.48	8.66	1.88	1.51	0.38	0.00	1.88	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	32.66	9.43	2.18	0.00	0.73	0.00	1.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	17.55	10.03	2.51	0.00	0.00	0.00	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	37.72	4.78	1.98	0.99	0.99	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	23.20	12.28	2.73	2.73	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	22.77	6.18	1.81	1.21	0.60	0.00	0.75	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	27.86	6.97	0.00	0.54	0.54	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	27.77	7.75	1.89	0.94	0.94	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	22.72	7.48	1.34	1.34	1.87	0.00	1.34	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	27.31	6.83	0.00	0.98	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	28.36	6.80	2.32	1.66	0.33	0.00	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	15.61	0.00	1.20	1.20	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	28.32	3.54	0.00	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	30.53	9.26	2.23	1.72	0.69	0.00	0.51	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	16.78	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	30.10	10.19	1.46	1.94	0.97	0.00	1.46	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	36.05	6.07	0.38	0.38	1.14	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	29.07	8.48	1.21	1.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	26.79	12.54	2.85	2.28	0.00	0.00	1.71	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	26.94	6.41	2.78	1.28	0.64	0.00	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	24.26	7.23	2.32	0.77	0.26	0.00	1.03	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	30.03	7.98	0.94	0.94	0.00	0.00	1.41	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	30.87	11.25	1.29	0.96	0.96	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	23.54	9.27	0.00	2.14	0.00	0.00	2.14	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	28.08	15.21	3.51	0.00	1.17	0.00	2.34	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	30.71	6.32	0.00	0.90	0.60	0.00	1.81	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	26.14	5.94	1.19	0.00	0.00	0.00	3.56	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	30.51	4.07	1.02	2.03	1.02	0.00	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	33.36	7.90	1.78	1.27	1.27	0.00	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	24.14	3.81	1.91	0.64	0.00	0.00	1.27	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	28.91	7.77	3.45	1.29	0.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	30.06	8.89	1.06	0.64	0.85	0.00	1.69	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	16.82	10.73	0.29	0.58	0.58	0.00	0.87	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	45.35	4.72	0.94	1.89	1.89	0.00	1.89	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	27.63	7.12	2.54	1.53	0.34	0.00	0.85	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	18.53	2.32	2.32	2.32	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	29.58	4.23	0.00	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	29.16	8.58	1.50	0.64	0.86	0.00	1.07	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	30.68	4.81	0.60	0.60	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	24.79	13.12	1.46	0.73	0.00	0.00	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	28.51	5.75	2.30	1.38	0.23	0.00	0.69	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	20.40	17.85	2.55	5.10	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	26.19	10.93	1.27	1.02	0.25	0.00	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	27.25	7.64	2.68	3.30	0.41	0.00	0.62	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	20.50	10.10	2.14	0.31	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	30.59	11.47	0.96	1.91	1.43	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	22.40	10.20	0.89	1.77	0.44	0.00	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	12.21	4.58	0.00	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	26.59	12.19	2.22	0.55	1.66	0.00	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	24.36	6.36	1.06	1.06	0.79	0.00	1.32	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	19.99	5.45	1.09	0.36	0.00	0.00	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	13.26	1.11	0.00	0.74	0.49	0.00	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	9.41	0.86	0.00	1.37	0.00	0.00	0.00	0.17
Astrocyte - cerebellum, donor3	11661-122F5	7.13	2.10	0.42	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	55.08	6.62	2.09	2.79	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	31.06	4.53	1.62	1.78	0.16	0.00	0.16	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	36.10	2.83	1.94	2.54	0.00	0.15	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	152.99	12.62	3.90	6.08	0.23	1.03	0.23	0.80
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	151.59	11.02	5.64	4.13	1.25	0.88	0.00	0.75
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	157.38	11.72	3.19	5.92	0.80	1.25	0.34	0.68
Basophils, donor1	12241-129G9	212.63	5.23	3.40	2.88	0.26	3.66	0.00	0.00
Basophils, donor2	12242-129H1	370.18	15.51	7.94	5.41	1.08	8.66	3.25	1.08
Basophils, donor3	12243-129H2	148.91	10.73	3.67	2.79	0.73	2.65	0.15	0.59
Bronchial Epithelial Cell, donor1	11511-119G8	53.04	5.39	0.65	2.59	0.22	0.00	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	8.23	0.00	0.00	0.46	0.00	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	7.17	0.00	0.00	7.17	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	17.57	2.51	0.00	1.26	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	11.44	1.25	0.00	0.83	0.21	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	19.11	1.61	0.00	0.92	0.00	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	105.09	23.21	3.42	3.42	1.98	0.00	1.62	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	268.97	25.56	4.43	6.90	1.55	1.03	1.55	1.55
Burkitt's lymphoma cell line:RAJI	10476-106I8	272.96	40.76	2.79	11.18	0.70	7.22	3.26	4.19
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	175.56	16.63	15.03	1.60	2.56	1.28	1.60	1.28
CD133+ stem cells - cord blood derived, pool1	12223-129E9	341.28	10.34	20.68	10.34	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	238.95	21.42	7.33	3.94	2.82	5.07	1.69	0.56
CD14+ Monocytes, donor2	11305-117B9	185.23	17.45	2.23	2.78	1.48	1.86	0.93	0.74
CD14+ Monocytes, donor3	11381-118B4	199.12	18.88	3.73	3.95	0.88	2.41	2.85	0.88
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	59.16	4.81	7.36	0.85	0.28	0.00	1.13	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	90.60	10.24	7.96	0.00	1.14	0.00	1.14	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	64.43	6.90	8.55	0.66	0.33	0.33	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	87.02	9.68	5.78	2.46	0.43	0.14	0.58	0.87
CD14+ monocytes - mock treated, donor2	11873-125C1	74.23	4.83	2.72	1.51	0.00	0.60	1.21	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	86.23	11.84	4.97	1.42	1.42	0.47	0.71	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	72.82	7.53	1.00	1.67	0.84	0.50	0.33	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	64.31	9.66	1.66	1.10	0.28	1.66	1.10	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	98.18	6.45	0.99	0.99	0.50	1.49	0.25	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	94.77	11.16	1.57	1.37	0.39	1.37	0.59	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	84.40	11.04	2.14	1.60	0.89	0.71	1.42	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	149.73	4.35	3.05	3.05	0.65	1.31	1.09	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	140.24	10.07	3.04	2.34	0.23	1.17	1.64	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	140.46	16.37	0.00	3.17	1.58	1.58	0.00	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	166.40	11.09	6.66	3.33	0.00	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	92.67	12.05	2.83	1.34	1.19	0.89	1.04	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	78.82	6.59	1.20	0.80	1.00	2.20	0.80	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	113.88	5.41	1.46	2.08	0.62	1.67	0.21	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	125.60	10.30	1.37	3.43	0.46	3.66	1.60	0.46
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	175.08	5.66	2.04	2.26	0.90	5.20	0.45	1.36
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	153.20	10.48	1.75	3.93	0.87	3.49	1.31	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	98.99	11.30	2.69	2.96	0.81	0.00	1.34	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	100.84	11.17	3.49	2.27	1.22	1.05	1.05	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	114.46	11.78	1.26	3.37	0.42	0.84	1.26	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	71.10	5.70	1.29	1.84	0.18	1.29	0.55	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	77.85	4.23	1.41	1.06	0.35	0.35	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	91.69	5.70	0.44	1.32	0.88	0.88	0.44	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	108.98	17.61	2.44	1.22	1.05	1.92	1.92	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	112.25	23.42	1.86	0.74	0.74	2.23	1.49	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	201.54	6.68	2.80	4.96	1.51	5.39	0.65	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	76.57	9.83	3.28	2.46	0.00	0.41	0.41	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	118.68	3.25	0.70	1.62	0.46	1.85	0.93	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	115.53	3.94	1.39	2.78	1.16	0.93	0.23	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	105.71	5.45	1.53	2.83	1.09	1.74	1.31	0.65
CD14+CD16+ Monocytes, donor2	11801-124D1	111.11	6.47	5.08	1.39	1.15	2.08	0.92	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	105.71	7.58	3.68	3.03	0.65	1.95	0.43	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	149.18	5.76	8.41	2.34	2.02	3.89	0.47	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	136.22	9.95	4.54	2.62	1.75	0.35	0.35	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	206.92	6.47	6.91	2.23	3.57	3.57	0.67	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	119.42	7.66	4.34	1.79	1.28	2.04	0.26	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	137.45	9.22	4.83	1.76	1.32	2.85	0.66	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	141.70	11.16	5.05	2.95	1.89	2.32	0.63	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	276.39	22.36	4.06	4.06	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	269.16	16.27	5.42	3.39	1.36	0.00	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	317.93	21.75	5.18	3.11	0.00	0.00	2.07	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	325.69	33.58	9.59	5.33	2.67	0.53	4.26	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	382.22	16.08	4.29	9.11	1.61	0.00	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	313.06	17.55	3.51	3.51	0.70	0.00	1.40	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	294.92	15.69	3.92	3.14	0.78	0.00	1.57	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	365.17	25.05	11.86	5.27	0.00	0.00	3.95	0.00
CD19+ B Cells, donor1	11544-120B5	311.50	46.03	2.47	4.11	2.47	1.64	6.58	1.64
CD19+ B Cells, donor2	11624-122B4	292.35	36.27	2.18	6.53	1.45	1.45	2.18	1.45
CD19+ B Cells, donor3	11705-123B4	348.33	36.35	2.52	8.58	1.01	5.05	4.04	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	157.58	8.08	4.85	2.83	2.02	2.42	0.40	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	111.46	15.98	3.20	1.60	0.40	3.60	1.60	0.80
CD34+ Progenitors, donor1	11545-120B6	127.51	4.02	8.03	2.01	0.00	1.00	1.00	2.01
CD34+ Progenitors, donor2	11625-122B5	383.15	14.05	0.00	6.18	1.12	3.37	0.56	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	237.85	27.05	8.27	9.02	2.25	1.50	1.50	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	250.29	16.91	14.21	6.31	2.03	0.90	2.25	2.25
CD4+ T Cells, donor1	11225-116C1	800.52	44.28	13.93	10.35	14.28	16.07	1.43	2.50
CD4+ T Cells, donor2	11306-117C1	586.03	97.98	9.19	9.19	11.02	3.06	6.74	1.84
CD4+ T Cells, donor3	11382-118B5	457.49	54.90	3.96	6.40	6.10	7.93	7.01	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	93.67	5.10	3.32	0.51	2.30	1.02	0.00	0.51
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	91.64	9.43	3.59	1.80	2.47	0.45	0.45	0.90
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	111.53	10.64	4.60	0.57	5.46	0.57	0.57	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	533.35	18.02	5.22	19.91	15.65	27.97	0.47	2.37
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	444.57	15.45	5.62	9.13	9.83	18.96	1.40	2.11
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	303.25	26.37	0.00	13.18	3.30	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	304.78	18.35	5.49	5.64	3.76	0.43	0.87	0.87
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	89.98	16.61	3.39	1.02	1.69	0.17	1.69	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	84.31	14.02	3.22	1.61	0.97	0.16	0.64	0.32
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	256.88	17.48	2.24	3.14	2.69	4.03	2.24	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	239.68	9.78	3.84	3.84	6.64	2.45	1.05	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	237.15	11.00	2.20	4.84	2.20	2.64	0.88	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	259.31	18.55	2.53	2.95	12.65	0.42	1.26	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	135.26	29.09	4.36	1.45	5.61	0.62	2.91	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	147.35	28.07	1.67	1.67	6.01	1.00	2.67	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	498.73	16.86	6.53	9.52	25.02	35.35	2.18	3.81
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	464.13	23.05	8.04	9.11	30.01	31.62	1.61	8.04
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	349.68	48.42	3.59	1.79	3.59	14.35	1.79	5.38
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	138.14	11.31	4.26	1.48	4.26	0.19	0.93	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	111.12	8.01	2.60	1.08	2.38	0.22	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	102.76	9.88	3.78	0.21	1.26	0.84	0.84	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	402.46	7.58	6.57	7.58	10.62	8.09	1.01	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	425.02	13.00	6.07	6.07	6.07	6.93	0.87	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	510.78	21.35	10.46	10.02	7.41	7.84	2.18	3.49
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	436.47	33.16	11.38	2.47	12.37	3.96	0.99	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	403.43	21.23	9.23	7.39	11.08	2.77	2.77	2.77
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	413.16	18.15	6.98	8.37	8.37	1.40	1.40	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	437.82	11.35	1.66	3.05	13.29	2.49	0.28	3.32
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	497.16	14.72	1.23	5.15	17.67	3.68	0.74	3.44
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	482.02	32.34	3.08	0.00	10.78	4.62	3.08	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	486.68	25.43	10.03	5.73	12.18	2.86	1.43	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	531.84	34.62	9.69	5.54	9.69	2.77	4.15	1.38
CD8+ T Cells, donor1	11226-116C2	852.54	48.45	6.88	12.11	2.62	20.95	1.96	6.55
CD8+ T Cells, donor2	11307-117C2	609.33	83.72	9.76	8.26	1.88	10.14	4.88	3.00
CD8+ T Cells, donor3	11383-118B6	629.20	72.72	6.31	10.60	5.05	8.84	9.85	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	90.84	7.11	0.23	3.67	0.00	1.15	0.00	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	87.23	5.51	0.24	3.59	0.00	0.24	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	94.39	6.57	0.27	2.74	0.00	0.55	0.55	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	109.58	6.90	0.30	4.20	0.00	1.20	0.60	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	94.79	7.68	1.20	3.36	0.00	0.48	0.72	0.72
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	114.15	6.14	0.45	3.64	0.00	1.14	0.68	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	97.34	7.82	0.00	4.78	0.22	0.22	0.43	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	94.75	7.37	0.26	2.90	0.00	0.26	0.53	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	98.26	5.16	0.47	3.05	0.00	0.47	0.23	0.70
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	137.35	10.26	0.91	5.74	0.30	2.42	0.60	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	129.56	9.01	0.58	4.07	0.00	1.45	1.16	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	156.13	6.13	0.53	2.66	0.00	1.07	0.00	1.33
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	159.78	13.13	0.00	3.50	0.00	0.88	0.88	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	164.41	7.74	0.46	5.47	0.00	1.37	1.82	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	129.04	9.70	0.75	5.97	0.00	2.24	2.24	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	123.53	6.48	0.36	5.04	0.36	2.16	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	115.09	10.65	0.00	4.60	0.00	1.15	1.44	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	101.11	5.89	0.47	3.77	0.00	1.18	0.00	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	133.10	5.39	0.95	6.34	0.00	0.00	0.63	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	135.02	5.84	0.31	3.69	0.00	0.92	0.62	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	128.87	8.98	0.64	3.85	0.00	0.64	0.32	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	156.43	6.12	0.00	3.44	0.00	1.15	0.76	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	150.15	9.06	0.79	4.73	0.00	0.79	0.79	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	129.35	7.56	0.76	2.27	0.00	0.76	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	288.26	14.45	1.61	8.83	0.00	4.82	2.41	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	286.77	14.69	1.40	2.80	0.70	7.69	3.50	3.50
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	321.56	17.03	0.00	13.02	0.00	3.01	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	180.95	7.31	9.14	3.66	1.83	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	36.56	6.42	2.47	0.99	0.00	0.00	1.98	0.00
Cardiac Myocyte, donor3	11686-122I3	30.31	2.53	1.37	0.95	0.32	0.00	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	74.88	10.40	0.35	3.12	0.69	0.00	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	44.42	2.84	1.78	2.84	0.71	0.00	0.36	0.00
Chondrocyte - de diff, donor3	11410-118E6	68.95	12.40	1.71	4.21	0.46	0.00	0.91	0.11
Chondrocyte - re diff, donor2	11339-117F7	102.95	4.48	0.90	3.58	2.69	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	39.23	3.24	0.81	1.21	0.40	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	75.28	5.97	4.13	2.64	1.15	0.00	0.00	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	57.93	10.90	1.92	3.63	0.21	0.00	2.14	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	52.48	7.08	1.86	3.72	0.53	0.00	0.18	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	79.23	4.03	5.59	2.93	0.55	0.18	0.09	0.37
Corneal Epithelial Cells, donor1	11526-119I5	17.13	0.66	0.88	0.22	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	53.47	7.96	0.00	2.28	1.14	0.00	2.28	0.00
Corneal Epithelial Cells, donor3	11687-122I4	30.93	3.32	0.00	1.53	0.26	0.00	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	78.59	8.25	4.79	1.16	1.16	0.17	0.50	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	75.70	8.83	4.10	0.63	1.89	0.00	0.95	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	72.46	3.45	6.90	0.00	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	62.63	8.75	4.10	0.32	0.43	0.00	0.54	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	335.49	29.04	6.83	2.73	0.00	8.54	2.39	1.37
Dendritic Cells - plasmacytoid, donor2	11309-117C4	312.07	11.10	2.61	3.26	1.96	4.57	0.00	3.26
Dendritic Cells - plasmacytoid, donor3	11385-118B8	379.41	9.19	0.48	0.97	0.00	4.36	0.48	1.45
Endothelial Cells - Aortic, donor0	11207-116A1	12.01	0.67	1.17	0.17	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	7.04	1.17	1.76	1.76	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	10.18	1.98	0.85	0.28	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	17.30	0.39	0.39	0.39	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	18.62	1.16	0.87	1.16	0.29	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	34.82	5.65	0.94	0.71	0.24	0.00	0.47	0.00
Endothelial Cells - Artery, donor3	11413-118E9	11.75	1.40	1.93	0.53	0.18	0.00	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	62.06	6.21	5.10	2.66	0.44	0.00	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	99.80	3.35	3.04	2.74	1.22	0.00	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	95.57	4.51	2.54	1.41	0.56	0.00	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	28.23	2.67	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	23.95	2.08	0.52	0.52	1.04	0.52	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	32.61	5.67	2.98	0.85	0.57	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	29.61	6.00	0.00	0.40	0.40	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	30.40	4.72	0.00	0.52	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	49.82	5.72	7.21	0.87	0.75	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor2	11324-117E1	37.80	4.35	4.78	0.43	0.87	0.00	0.65	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	27.48	1.83	3.42	0.61	0.37	0.00	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	7.96	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	6.99	0.00	1.40	2.10	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	11.15	1.41	1.73	0.94	0.16	0.00	0.00	0.00
Eosinophils, donor1	12244-129H3	442.16	0.00	0.00	0.00	15.25	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	1871.40	33.01	26.40	21.45	9.90	31.35	0.00	9.90
Eosinophils, donor3	12246-129H5	1508.77	39.24	21.40	7.13	0.00	10.70	7.13	3.57
Esophageal Epithelial Cells, donor1	11507-119G4	25.17	1.47	0.24	0.49	0.24	0.00	0.00	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	56.65	14.37	2.46	4.52	0.41	0.41	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	10.40	1.42	0.33	0.99	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	15.60	3.14	0.87	0.65	0.11	0.00	0.22	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	38.93	3.76	3.03	1.46	0.36	0.00	0.24	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	78.20	5.87	1.77	3.96	0.14	0.14	0.00	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	34.17	4.01	2.11	1.48	0.63	0.00	0.32	0.00
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	52.43	3.69	0.79	1.58	1.32	0.53	0.00	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	33.22	3.65	1.99	1.66	0.33	0.00	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	22.23	1.36	0.00	0.91	0.45	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	9.85	1.52	0.00	0.00	0.00	0.00	0.76	0.00
Fibroblast - Cardiac, donor3	11417-118F4	22.08	3.15	1.58	1.26	0.63	0.00	0.00	0.00
Fibroblast - Cardiac, donor4	11452-119A3	69.71	4.24	3.64	2.42	0.91	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	28.05	2.28	0.25	1.14	0.25	0.00	0.51	0.00
Fibroblast - Cardiac, donor6	11460-119B2	20.62	2.58	0.15	0.15	0.00	0.00	0.00	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	55.74	2.01	0.40	4.82	0.13	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	113.90	12.94	2.16	6.47	0.86	0.43	0.86	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	26.37	7.32	2.93	4.39	1.46	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	6.92	1.15	0.23	0.23	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	132.29	9.84	4.75	4.41	0.34	0.00	0.51	0.17
Fibroblast - Dermal, donor1	11269-116G9	68.09	7.28	0.70	2.35	0.47	0.00	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	19.81	1.89	0.47	1.42	0.00	0.00	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	55.97	9.55	2.18	1.33	0.36	0.00	0.97	0.00
Fibroblast - Dermal, donor4	11450-119A1	22.50	2.71	0.57	0.68	0.57	0.00	0.00	0.23
Fibroblast - Dermal, donor5	11454-119A5	16.22	1.40	0.17	0.35	0.70	0.00	0.00	0.17
Fibroblast - Dermal, donor6	11458-119A9	20.30	1.62	0.16	0.32	0.16	0.16	0.00	0.49
Fibroblast - Gingival, donor1	11237-116D4	72.05	5.41	3.12	3.96	0.62	0.00	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	63.40	3.41	2.10	2.88	0.26	0.00	0.00	0.00
Fibroblast - Gingival, donor2	11318-117D4	19.77	3.82	0.92	0.66	0.92	0.00	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	80.25	3.38	3.77	3.77	1.26	0.10	0.10	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	42.59	4.16	4.16	3.12	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	26.43	3.35	1.23	0.70	0.18	0.00	0.35	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	20.58	2.34	0.94	0.62	0.47	0.00	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	41.38	3.65	0.95	1.76	0.14	0.14	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	21.17	0.35	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	26.47	2.05	1.90	1.17	0.44	0.00	0.00	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	56.86	4.09	1.91	1.09	0.41	0.00	0.14	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	20.73	2.08	1.32	0.99	0.22	0.00	0.22	0.11
Fibroblast - Gingival, donor9 (control)	11927-125I1	40.50	2.49	3.82	1.32	1.17	0.00	0.00	0.29
Fibroblast - Lung, donor1	11270-116H1	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	43.27	1.49	1.49	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	26.80	3.38	0.84	0.42	0.21	0.00	0.63	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	13.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	13.99	0.00	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	3.08	0.28	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	20.30	0.41	1.22	0.81	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	17.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	31.62	4.27	2.33	0.97	0.39	0.00	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	34.74	2.73	1.67	1.67	1.52	0.00	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	52.63	1.53	2.14	1.84	0.92	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	31.67	6.11	1.14	2.67	0.38	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	36.99	6.48	1.89	1.62	0.27	0.00	0.81	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	31.78	4.52	2.32	1.16	0.46	0.12	0.23	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	32.61	5.64	1.77	0.77	0.22	0.00	0.55	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	12.39	0.20	0.61	0.81	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	11.36	2.00	0.67	0.00	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	47.44	8.30	2.77	3.56	0.40	0.00	1.58	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	38.30	1.59	0.40	0.79	0.40	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	49.91	4.09	1.24	0.18	0.18	0.00	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	47.50	4.34	2.37	1.58	0.00	0.20	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	27.98	3.91	0.30	0.60	0.90	0.00	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	72.11	4.10	0.54	1.94	0.54	0.00	0.00	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	79.21	5.31	0.76	2.78	0.51	0.25	0.51	0.25
Fibroblast - skin normal, donor1	11553-120C5	55.29	3.77	1.97	1.31	0.49	0.00	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	46.52	4.21	3.01	2.41	0.60	0.00	0.40	0.00
Fibroblast - skin normal, donor2	11561-120D4	49.13	2.11	0.20	1.41	1.21	0.00	0.10	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	75.86	2.42	1.51	3.93	1.21	0.00	0.60	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	68.35	5.63	2.90	0.83	0.17	0.00	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	151.29	9.74	0.34	4.79	0.51	0.00	0.34	0.00
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	48.61	2.96	1.31	2.96	0.33	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	46.23	3.20	0.64	0.75	0.43	0.00	0.21	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	21.42	0.67	0.51	1.35	0.17	0.00	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	35.91	2.04	2.20	0.94	0.00	0.00	0.16	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	443.20	66.48	22.16	22.16	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	563.88	23.53	5.23	22.66	8.72	1.74	2.61	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	92.75	6.93	2.25	3.81	0.17	0.00	1.04	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	86.14	9.11	2.86	2.60	0.52	0.00	0.26	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	76.65	5.37	2.81	2.30	0.26	0.00	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	13.01	5.36	0.77	0.00	0.77	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	16.59	3.19	1.28	0.00	0.64	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	29.95	8.84	2.57	3.14	0.86	0.00	0.57	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	87.14	19.58	5.24	4.41	0.55	0.00	1.10	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	68.73	15.30	3.88	5.71	0.68	0.23	2.05	2.05
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	33.48	8.92	2.18	2.18	0.20	0.20	0.20	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	64.50	20.88	1.59	4.23	0.53	0.00	2.64	1.85
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	77.30	12.72	3.59	4.24	0.33	0.00	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	31.40	8.84	1.77	0.88	1.33	0.00	1.33	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	40.42	4.38	2.12	2.83	0.28	0.00	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	56.89	5.54	1.23	2.96	0.62	0.12	0.86	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	22.30	3.22	2.15	2.15	0.54	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	47.08	4.34	1.61	2.85	0.37	0.00	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	41.25	3.46	1.11	1.38	0.42	0.14	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	23.58	3.86	1.02	1.63	0.20	0.00	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	46.09	8.21	2.97	3.65	0.00	0.00	0.91	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	62.28	5.36	1.37	3.36	0.62	0.00	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	66.23	5.03	3.50	3.50	0.66	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	62.64	11.23	1.77	2.66	0.89	0.00	0.59	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	57.22	6.20	1.11	3.97	0.64	0.16	0.64	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	46.47	3.35	1.56	4.02	0.00	0.00	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	57.26	10.48	2.42	2.02	0.40	0.00	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	64.97	4.75	2.71	2.71	0.17	0.00	0.34	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	66.15	4.08	1.68	1.86	0.53	0.18	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	83.04	5.83	3.75	3.33	1.04	0.10	0.10	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	73.95	4.78	2.73	2.90	1.20	0.00	0.17	0.68
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	77.24	5.09	2.99	3.65	0.77	0.00	0.55	0.22
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	75.71	7.65	1.91	2.83	0.50	0.00	0.08	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	76.98	5.10	0.82	3.88	1.02	0.41	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	63.54	10.32	4.13	2.06	0.83	0.00	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	69.87	9.68	2.19	2.31	0.81	0.23	0.58	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	50.36	5.50	2.67	2.17	0.33	0.00	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	59.74	10.36	4.63	2.42	0.44	0.00	1.32	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	75.52	8.12	3.20	2.71	0.49	0.00	0.61	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	52.52	6.81	2.43	1.78	0.32	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	68.63	15.07	5.45	1.28	0.64	0.00	0.96	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	55.91	6.73	2.94	3.51	0.85	0.00	0.47	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	45.08	6.33	2.53	1.74	0.79	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	67.20	9.12	2.74	0.61	0.91	0.00	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	62.62	8.36	2.30	2.61	0.84	0.10	0.42	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	53.13	9.66	1.98	1.76	0.66	0.00	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	64.53	6.45	1.68	2.52	1.12	0.00	0.56	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	42.03	3.52	1.48	1.94	0.65	0.00	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	42.78	7.49	1.07	2.67	0.53	0.00	0.80	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	32.44	4.59	1.68	1.68	0.00	0.00	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	31.74	3.63	0.78	1.42	0.13	0.00	0.52	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	56.11	8.40	1.90	4.07	1.63	0.00	0.54	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	49.04	10.14	2.58	2.77	0.37	0.00	0.55	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	54.39	5.70	3.73	1.75	0.44	0.00	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	89.26	2.98	5.95	5.95	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	31.26	4.49	3.17	1.85	0.79	0.00	0.13	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	25.22	6.86	2.42	1.01	0.40	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	88.96	4.57	4.07	4.07	0.51	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	27.27	2.19	0.40	2.59	0.60	0.00	0.00	0.20
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	25.88	4.01	1.54	1.23	0.46	0.00	0.31	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	29.87	4.09	0.82	1.84	1.02	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	14.08	3.44	1.25	0.31	0.94	0.00	0.31	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	11.87	3.11	2.54	1.13	0.57	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	16.60	2.31	1.38	0.00	0.46	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	2.47	4.95	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	25.14	5.80	0.39	2.71	0.39	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	20.86	22.46	0.00	1.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	12.17	0.00	1.74	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	24.41	6.84	0.65	2.28	0.00	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	39.94	7.41	2.06	2.88	0.00	0.00	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	56.65	19.99	0.00	3.33	0.00	0.00	6.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	29.64	8.95	0.84	1.40	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	33.01	8.82	1.31	1.31	0.00	0.00	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	40.26	9.23	1.68	3.36	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	48.98	7.32	1.59	0.32	0.95	0.00	0.32	0.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	37.36	9.17	1.36	2.38	0.00	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	29.23	8.35	0.00	4.18	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	55.55	13.17	2.86	3.44	0.57	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	33.45	11.84	3.26	1.78	0.30	0.00	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	69.46	32.19	3.39	3.39	0.00	1.69	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	80.77	16.57	1.24	3.73	0.83	0.83	1.66	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	77.09	12.43	1.38	5.06	0.69	0.23	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	21.07	0.00	15.81	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	79.57	18.45	0.77	5.00	0.77	0.38	1.15	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	77.91	16.62	1.96	3.26	0.65	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	67.55	16.72	4.68	2.01	0.00	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	92.85	14.64	3.08	5.39	0.39	0.00	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	64.36	11.64	0.34	2.05	0.34	0.34	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	84.48	19.88	0.00	0.00	4.97	0.00	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	75.02	18.87	0.94	0.94	0.47	0.00	0.94	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	85.70	24.14	0.60	1.21	1.21	0.00	1.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	93.09	12.21	0.51	5.09	0.51	0.51	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	94.52	16.35	3.59	3.59	1.60	0.00	0.40	0.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	120.38	27.13	0.99	2.96	0.99	0.99	1.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	110.96	28.33	5.90	4.72	0.00	0.00	1.18	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	100.35	35.59	2.33	3.50	0.58	0.00	3.50	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	102.70	16.68	2.19	1.32	0.44	0.00	1.32	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	73.75	17.80	4.24	3.39	0.85	0.00	3.39	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	55.51	14.92	0.60	1.19	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	108.70	17.95	0.97	5.82	0.97	0.00	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	3.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	36.59	6.24	2.49	2.08	0.42	0.00	1.25	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	9.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	60.26	11.73	4.44	3.17	0.63	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	76.86	14.20	2.09	1.25	0.42	0.00	1.25	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	71.48	14.27	3.02	8.82	0.35	1.39	2.20	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	85.41	20.42	3.21	7.76	0.17	1.01	0.68	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	64.61	13.20	1.59	6.14	0.46	1.14	0.91	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	64.60	18.04	3.39	6.12	0.11	0.55	1.09	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	72.21	12.89	1.93	7.74	0.21	1.93	1.50	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	56.40	13.99	3.01	5.38	0.00	0.43	0.43	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	74.72	20.92	2.37	8.22	0.25	0.87	1.87	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	59.53	17.50	1.72	8.06	0.17	0.86	0.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	55.74	10.89	0.96	7.69	0.32	0.32	0.96	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.75	0.00	0.00	1.12	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	4.33	0.87	0.00	0.00	0.43	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	0.00	0.00	2.64	0.00	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	9.88	0.00	0.71	0.00	0.35	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	6.54	1.45	0.00	0.73	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	19.23	5.77	0.70	1.05	0.17	0.00	0.17	0.00
Hepatocyte, donor1	11523-119I2	70.21	18.16	2.42	2.42	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	74.34	9.70	1.08	2.15	0.00	0.00	1.08	0.00
Hepatocyte, donor3	11684-122I1	82.21	14.72	1.84	1.84	0.00	0.00	0.61	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	43.73	1.96	6.53	0.65	1.31	0.00	0.00	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	151.54	6.82	3.15	11.71	0.70	0.00	0.00	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	50.63	5.90	2.33	2.47	0.41	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	9.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	13.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	6.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	7.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	4.87	0.00	0.00	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	5.00	1.67	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	14.52	0.00	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	0.00	2.22	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	5.04	0.00	0.00	1.89	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	8.40	0.65	0.00	0.00	0.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	8.15	0.00	0.00	0.81	0.00	0.00	0.00	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	3.78	0.00	0.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.04	0.00	0.00	0.80	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	4.62	0.00	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	7.55	0.94	0.94	0.47	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	3.63	0.00	0.00	0.00	0.00	0.91	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	5.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	2.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	5.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	4.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	3.32	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	4.32	0.62	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	1.76	0.00	1.76	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	6.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	3.48	0.70	0.00	0.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	3.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	15.69	0.00	0.87	0.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00	2.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	6.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	18.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	5.54	0.00	1.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	5.29	0.00	0.00	0.00	0.00	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	78.74	8.89	2.45	1.96	1.06	0.16	0.08	0.08
Keratinocyte - epidermal, donor2	11349-117G8	13.47	1.17	0.00	0.59	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	29.15	3.88	1.51	0.47	0.28	0.00	0.09	0.09
Keratinocyte - oral, donor1	11251-116E9	298.10	25.88	10.56	13.74	1.82	0.11	0.79	0.11
Keratocytes, donor1	11527-119I6	5.16	0.34	0.00	0.00	0.00	0.34	0.00	0.00
Keratocytes, donor2	11607-120I5	7.03	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	25.69	2.57	1.19	1.38	0.00	0.00	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	37.36	2.20	2.20	0.00	6.59	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	29.13	4.31	1.08	1.08	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	46.82	4.50	2.65	2.54	0.46	0.00	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	94.05	3.53	3.53	5.95	0.81	0.10	0.10	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	28.22	3.32	2.49	0.83	0.24	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	17.02	5.58	1.67	0.84	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	49.27	11.65	1.89	2.36	0.47	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	16.67	3.23	1.08	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.66	1.26	0.95	0.32	0.00	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	21.24	3.88	1.19	1.83	0.00	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	29.55	4.92	0.82	0.41	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	8.85	2.28	0.25	0.25	0.00	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	23.36	3.80	0.84	1.55	0.00	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.55	3.96	0.79	0.79	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	18.42	4.65	0.39	0.58	0.00	0.00	0.58	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	7.59	3.15	0.19	0.37	0.19	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	23.69	5.92	1.39	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	16.22	2.86	1.67	0.48	0.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	19.23	3.85	0.96	0.14	0.14	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	25.25	6.47	1.54	0.62	0.31	0.00	1.54	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	6.86	1.56	0.31	0.00	0.31	0.00	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	20.49	4.03	1.10	0.37	0.18	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	20.73	5.59	0.99	0.99	0.66	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	9.37	2.34	0.29	0.29	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	12.70	3.24	0.25	0.00	0.25	0.00	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	19.40	6.30	1.45	0.48	0.48	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	21.01	6.46	0.81	0.54	0.00	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	28.31	5.00	0.76	0.61	0.00	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	17.11	5.70	1.04	0.52	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	23.24	4.61	1.05	0.84	0.21	0.00	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	23.16	5.26	1.35	0.45	0.15	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	17.88	7.57	2.06	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	17.69	2.07	1.32	0.19	0.19	0.00	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	19.51	3.92	0.85	1.27	0.11	0.00	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	25.20	5.33	0.97	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	15.88	2.32	0.00	0.99	0.33	0.00	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	20.69	4.83	0.37	0.62	0.00	0.00	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	39.61	4.81	2.96	1.11	0.74	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	20.26	3.21	1.48	0.25	0.74	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	16.36	2.89	0.69	0.41	0.14	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	27.02	4.18	1.29	0.32	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	27.39	7.61	0.91	0.91	0.30	0.00	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	39.75	7.42	1.40	1.96	0.00	0.00	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	23.82	6.40	0.36	0.36	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	9.21	2.42	0.97	0.48	0.00	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	11.20	3.27	0.78	0.31	0.00	0.00	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	15.40	4.66	0.72	0.36	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	16.33	2.29	0.33	0.00	0.33	0.00	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	13.89	2.35	0.24	0.94	0.00	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	24.01	1.61	1.24	0.87	0.37	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	11.01	1.79	0.51	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	23.57	2.39	0.60	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	24.93	0.00	2.27	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	28.38	6.14	0.77	3.84	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	25.98	0.74	0.00	2.97	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	41.47	8.46	0.42	0.85	0.00	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	33.76	5.63	2.81	2.81	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	21.48	0.00	0.00	2.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	29.89	4.12	0.52	1.03	0.52	0.00	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	21.41	2.38	0.00	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	40.26	1.58	1.13	3.39	0.68	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	39.26	14.54	0.87	2.33	0.58	0.29	1.16	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	49.52	10.80	0.45	3.15	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	44.44	1.63	0.81	2.03	0.14	0.14	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	29.27	7.70	0.00	1.03	1.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	44.11	10.23	1.76	5.29	0.00	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	41.98	8.00	1.33	5.33	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	42.28	2.55	0.00	3.57	0.51	0.00	1.02	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	52.83	7.74	0.27	3.20	0.80	0.00	0.80	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	51.39	6.42	0.38	3.78	0.00	0.00	0.76	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	32.52	8.59	0.00	3.07	0.61	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	39.96	6.52	0.82	4.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	48.31	10.83	0.21	2.50	0.00	0.21	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	48.77	12.33	0.84	5.04	0.56	0.00	0.56	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	30.91	2.06	0.00	2.06	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	42.38	9.00	0.29	2.03	0.00	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	34.97	8.67	0.30	1.79	0.30	0.30	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	39.83	4.98	1.11	2.21	0.00	0.55	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	36.06	6.01	1.41	3.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	23.97	8.11	0.37	0.74	0.37	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	24.18	2.30	1.15	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	28.40	4.61	0.38	3.07	0.00	0.00	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	19.25	3.40	0.57	1.70	0.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	24.61	1.64	0.00	2.46	0.00	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	27.11	3.16	0.00	0.90	0.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	27.29	4.31	0.72	2.15	0.00	0.72	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	37.35	1.49	0.00	4.48	0.00	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	33.81	3.34	0.00	2.97	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	40.06	8.18	0.00	1.29	0.00	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	37.68	5.14	0.86	1.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	29.99	5.00	0.00	1.67	0.33	0.00	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	54.30	4.83	1.21	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	31.99	2.13	0.00	2.84	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	31.62	2.75	0.69	1.72	0.34	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	40.26	3.76	1.07	1.61	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	30.97	2.02	0.00	1.35	1.35	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	37.78	5.56	1.48	1.11	0.74	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	52.33	1.16	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	34.91	2.12	0.00	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	27.21	2.00	0.40	2.00	0.80	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	36.34	4.36	0.00	2.18	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	29.89	2.30	0.00	3.83	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	33.05	3.45	0.00	2.47	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	25.41	3.76	0.00	1.88	0.00	0.00	1.88	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	30.67	3.52	0.50	2.01	0.50	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	34.25	3.15	0.90	0.45	0.45	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	24.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	32.96	3.56	0.45	2.67	0.89	0.00	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	40.28	5.47	0.39	1.56	0.00	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	32.33	3.96	0.00	1.98	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	37.88	6.23	0.52	2.08	1.04	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	48.57	3.50	0.44	3.94	0.00	0.00	1.31	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	38.02	9.50	0.00	1.12	0.56	0.00	0.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	34.45	2.21	0.44	1.77	0.88	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	32.79	4.63	0.39	2.31	0.39	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	29.37	5.06	0.00	2.03	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	33.16	6.25	0.96	1.92	0.00	0.48	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	31.01	7.16	0.40	1.99	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	33.42	6.68	0.00	1.82	0.61	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	22.13	1.38	0.00	0.69	0.00	0.00	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	34.96	3.42	0.38	2.28	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	25.82	3.10	0.00	2.58	0.00	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	18.14	2.42	0.00	1.21	1.21	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	25.35	5.39	0.63	1.90	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	20.26	3.73	0.00	1.07	0.53	0.53	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	16.09	1.72	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	20.57	2.57	0.51	2.57	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	14.15	1.41	0.00	2.83	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	15.89	1.13	0.00	2.27	1.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	25.79	1.66	0.42	1.66	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.88	3.13	0.00	0.78	0.78	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	13.36	1.67	0.00	0.42	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	14.87	0.93	0.46	1.39	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	19.40	2.01	0.00	2.01	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	13.37	1.60	0.00	1.60	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	17.78	2.83	0.00	2.42	0.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	14.68	0.92	0.00	0.92	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	9.78	0.00	0.00	1.78	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	17.10	2.85	0.00	2.28	1.14	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	17.64	0.77	0.77	2.30	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	15.32	1.09	1.09	0.55	1.09	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	19.15	0.45	0.00	0.45	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	23.66	0.26	0.26	2.08	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.91	0.66	0.00	0.00	0.00	0.00	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	24.94	6.24	0.00	0.00	2.08	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	28.95	4.79	5.93	0.46	1.14	0.23	0.46	0.00
Macrophage - monocyte derived, donor2	11313-117C8	25.14	1.47	2.02	0.18	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	24.64	4.33	4.46	0.13	0.66	0.00	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	49.92	2.12	1.59	1.06	0.00	0.00	1.06	0.00
Mallassez-derived cells, donor2	11929-125I3	96.18	3.80	2.69	5.86	0.00	0.16	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	74.78	3.75	2.08	2.92	0.14	0.00	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	171.88	27.70	4.09	6.58	2.39	2.39	0.70	0.90
Mammary Epithelial Cell, donor2	11350-117G9	115.24	12.16	1.74	6.66	1.16	1.74	1.16	0.87
Mammary Epithelial Cell, donor3	11422-118F9	26.19	2.00	2.00	2.00	0.75	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	336.26	8.14	6.10	2.71	0.00	4.07	0.00	1.36
Mast cell, donor1	11563-120D6	342.16	17.19	4.33	9.30	0.11	0.87	0.32	2.16
Mast cell, donor2	11565-120D8	706.68	25.56	16.94	22.29	5.05	2.67	0.59	2.97
Mast cell, donor3	11566-120D9	815.63	37.60	18.91	20.49	2.70	3.15	2.03	2.25
Mast cell, donor4	11567-120E1	705.97	33.33	17.55	23.58	4.25	2.84	1.06	4.25
Mast cell, expanded and stimulated, donor5	11940-126A5	224.56	9.65	8.32	3.77	0.89	1.22	0.33	1.44
Mast cell, expanded and stimulated, donor8	11942-126A7	140.08	7.59	1.75	3.50	0.00	0.58	1.75	2.33
Mast cell, expanded, donor5	11939-126A4	297.36	15.95	6.77	5.62	1.03	0.69	1.84	0.92
Mast cell, expanded, donor8	11941-126A6	454.40	22.26	7.87	5.86	1.51	1.51	1.34	1.51
Melanocyte - dark, donor1	11502-119F8	123.97	11.54	2.69	4.08	0.40	0.00	0.50	0.10
Melanocyte - dark, donor2	11582-120F7	36.34	6.92	3.46	0.69	0.00	0.00	1.04	0.00
Melanocyte - dark, donor3	11663-122F7	54.84	5.58	2.10	2.46	0.36	0.36	0.22	0.36
Melanocyte - light, donor1	11274-116H5	18.34	0.24	0.24	0.71	0.00	0.00	0.00	0.24
Melanocyte - light, donor2	11351-117H1	8.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	10.41	1.73	0.87	0.00	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	33.11	3.02	1.04	0.83	0.21	0.42	0.31	0.00
Melanocyte, donor2 (MC+2)	12739-135I3	41.42	9.41	0.54	0.81	0.27	0.81	1.61	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	59.73	7.23	2.41	2.41	0.27	0.00	0.54	0.00
Meningeal Cells, donor1	11493-119E8	36.97	1.36	0.00	1.74	0.25	0.00	0.00	0.12
Meningeal Cells, donor2	11573-120E7	31.25	1.32	0.00	3.96	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	62.59	10.92	1.71	3.02	0.24	0.08	0.33	0.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	64.16	7.13	3.42	3.71	1.14	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	39.55	3.32	1.71	1.21	0.30	0.00	0.00	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	0.00	1.31	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	7.85	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	20.09	1.44	2.15	0.72	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	30.49	0.42	0.64	0.85	0.21	0.00	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	30.66	4.02	1.51	0.50	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	7.47	0.88	0.44	0.22	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.84	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.12	0.82	0.20	0.20	0.00	0.00	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	56.93	3.88	0.14	1.66	0.83	0.00	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	16.73	0.37	0.00	1.12	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	37.76	5.00	1.97	1.97	0.00	0.00	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	47.78	1.78	1.19	0.59	0.00	0.00	0.30	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	0.00	0.00	2.34	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	11.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	27.29	2.13	0.71	1.42	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	40.65	6.57	2.19	1.25	0.00	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	13.79	3.63	1.45	0.73	0.73	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	37.65	5.04	4.51	0.53	0.00	0.00	1.33	0.00
Mesothelial Cells, donor2	12156-128G5	26.52	1.50	0.50	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	28.76	4.26	2.89	1.73	0.22	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	47.26	4.05	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	42.61	7.39	4.68	0.74	0.00	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	42.40	3.53	5.01	0.29	0.59	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	0.00	6.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	29.75	4.65	1.86	0.00	0.62	0.00	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	31.94	4.56	2.70	0.41	0.21	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	0.00	4.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	33.28	4.50	2.00	1.50	0.00	0.00	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	47.48	3.72	4.19	0.00	0.93	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	31.90	4.47	1.22	0.00	0.20	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	36.43	5.94	3.17	0.40	0.79	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	19.47	2.65	1.77	0.00	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	31.53	5.70	2.28	1.52	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	25.00	2.63	2.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	24.41	4.03	1.49	0.21	0.21	0.00	0.85	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	25.78	0.92	1.84	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	16.99	3.28	0.89	0.00	0.60	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	25.15	3.35	3.35	1.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	24.09	5.77	1.25	0.25	0.00	0.00	0.75	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	32.09	7.61	1.43	0.00	0.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	22.12	0.00	2.21	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	18.42	2.76	1.84	0.46	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	26.92	2.10	1.47	0.00	0.21	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	12.84	1.02	1.83	0.41	0.20	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	18.02	5.79	1.93	0.21	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	31.79	3.33	1.78	0.00	0.22	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	10.73	1.31	1.97	0.22	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	16.22	3.55	3.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	6.63	0.00	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	11.14	2.17	2.17	0.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	23.53	2.06	2.06	0.29	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	8.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	2.40	0.00	0.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	15.61	3.20	1.60	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	1.37	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	7.01	1.50	0.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	5.26	0.44	0.44	0.00	0.00	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	13.24	4.41	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	5.76	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	4.96	0.74	0.74	0.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	10.44	0.70	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	9.23	1.71	1.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	8.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.07	0.00	0.71	0.00	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	5.33	1.96	1.40	0.00	0.00	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	8.31	0.00	1.25	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	7.58	0.00	2.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.16	1.51	0.60	0.30	0.30	0.00	0.00	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	9.60	0.83	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	0.00	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	1.85	0.92	0.00	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	18.78	1.71	0.57	0.57	1.14	0.00	0.57	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	19.76	1.66	0.97	0.28	0.14	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	12.96	2.85	0.78	0.00	0.26	0.00	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	18.87	3.00	1.29	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.97	0.64	1.91	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	11.48	2.67	1.60	0.53	0.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	36.82	5.69	2.39	0.30	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	19.78	0.85	2.83	0.14	0.28	0.00	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	13.70	5.10	0.32	0.64	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	38.48	3.32	0.88	0.66	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	21.24	0.00	1.90	0.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	20.74	4.83	1.70	0.00	0.28	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	24.33	4.18	2.70	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	31.93	5.21	4.56	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	21.17	6.47	3.82	0.59	0.00	0.00	0.59	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	33.45	5.19	2.88	0.00	0.00	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	44.10	6.59	4.12	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	26.20	2.98	2.68	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	11.30	3.77	0.00	0.00	0.00	3.77	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	14.26	3.56	3.56	0.00	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	20.04	5.59	3.29	0.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	25.25	6.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	22.14	5.73	4.74	0.20	0.79	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	27.94	5.59	6.52	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	36.43	9.76	4.88	0.00	1.13	0.00	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	23.70	8.26	2.93	0.00	0.27	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	17.08	1.58	2.49	0.00	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	4.42	4.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	16.86	3.30	2.20	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	28.00	12.44	1.56	0.00	0.00	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	13.36	2.14	0.53	0.00	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	1.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	12.65	6.75	1.69	0.00	0.42	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	35.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.27	0.00	0.00	0.00	0.64	0.00	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	3.24	0.00	0.81	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	3.02	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	296.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	195.75	3.26	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	71.29	4.75	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	0.00	0.00	0.00	0.00	0.00	12.55	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	81.22	6.03	0.65	5.82	0.65	0.22	0.65	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	94.59	11.50	1.05	2.61	0.00	0.52	2.09	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.68	0.67	0.67	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.02	0.83	0.00	0.42	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	37.08	1.90	2.85	1.33	0.57	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	76.60	0.00	3.19	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	2.72	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	106.58	11.03	3.68	5.51	1.84	0.00	0.00	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.12	4.19	0.84	0.00	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	26.27	1.39	1.16	1.39	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	14.59	2.43	0.81	0.27	0.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	44.15	7.57	1.89	0.84	0.42	0.00	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	534.47	66.81	33.40	22.27	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	18.37	0.99	2.48	1.49	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	39.52	3.52	3.79	2.44	1.08	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	29.47	3.85	2.04	1.13	0.68	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	17.64	1.96	1.14	0.65	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	43.19	8.38	2.55	1.09	0.18	0.18	0.73	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	27.05	3.71	4.77	2.12	0.53	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	18.01	3.60	1.80	1.20	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	76.14	4.92	5.25	3.28	0.66	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	23.26	3.25	1.79	1.14	0.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	65.08	8.47	2.29	1.41	0.53	0.00	0.88	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	17.58	4.22	2.11	2.81	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	31.26	3.68	3.22	2.30	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	20.24	1.93	0.96	0.96	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	147.61	6.21	4.83	5.52	0.34	0.34	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	316.06	12.64	20.23	22.76	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	50.13	5.35	2.23	2.01	0.67	0.00	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	20.75	1.69	1.69	0.42	0.00	0.00	0.85	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	58.63	4.75	3.56	0.47	0.24	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	15.88	2.58	2.15	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	1227.78	27.08	9.03	27.08	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	17.33	1.67	0.33	0.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	35.62	3.61	1.35	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	13.89	0.79	1.59	0.00	0.40	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	18.57	0.93	3.71	1.86	0.93	0.00	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	37.46	2.65	1.14	0.00	0.38	0.00	0.76	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	15.97	1.30	0.65	0.33	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.51	1.31	1.31	0.87	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	46.59	5.43	0.90	0.90	0.45	0.45	0.45	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	12.35	5.29	1.76	0.88	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	17.29	3.32	2.66	1.33	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	21.33	1.98	1.49	0.50	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	18.76	3.06	0.38	0.38	0.77	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	59.28	3.02	2.72	1.21	0.30	0.00	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	48.18	7.51	1.33	1.99	1.33	0.66	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	10.84	0.68	1.36	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	454.75	40.88	20.44	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	17.68	1.83	0.61	1.22	0.61	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	28.96	4.72	1.89	0.31	0.31	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	15.44	2.12	1.21	0.30	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	11.87	0.79	0.79	0.79	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	106.56	5.67	4.53	5.67	0.00	0.00	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	409.69	35.41	35.41	5.06	15.17	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	35.41	3.60	1.86	1.61	0.00	0.12	0.25	0.00
Myoblast, donor2	11322-117D8	48.91	9.78	4.41	2.69	1.34	0.00	0.77	0.00
Myoblast, donor3	11398-118D3	43.22	2.52	2.86	2.02	0.50	0.17	0.00	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	58.37	9.49	3.06	1.31	1.31	0.00	0.44	0.00
Natural Killer Cells, donor1	11230-116C6	668.23	31.67	7.38	5.84	4.31	15.07	1.85	4.00
Natural Killer Cells, donor2	11311-117C6	426.40	60.61	7.24	7.54	3.32	3.92	4.22	1.51
Natural Killer Cells, donor3	11387-118C1	390.19	42.52	9.20	7.73	2.76	5.15	5.34	2.39
Neural stem cells, donor1	11275-116H6	50.45	3.27	3.63	1.81	0.00	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	63.55	1.93	0.00	1.93	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	17.07	3.41	1.14	0.00	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	31.48	3.30	1.10	1.10	0.22	0.00	0.44	0.00
Neurons, donor3	11655-122E8	16.44	3.29	0.00	3.29	0.00	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	756.32	17.63	17.63	10.21	2.78	14.85	7.42	18.56
Neutrophils, donor2	11314-117C9	495.71	46.38	14.49	0.00	0.00	2.90	0.00	20.29
Neutrophils, donor3	11390-118C4	835.63	3.67	13.44	15.88	4.28	17.10	0.00	29.93
Nucleus Pulposus Cell, donor1	11252-116F1	76.35	7.12	5.11	2.37	0.71	0.00	0.36	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	24.42	9.44	0.33	0.33	0.00	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	31.29	4.01	0.40	1.60	0.20	0.00	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	36.34	8.12	3.17	1.65	0.41	0.00	0.55	0.00
Olfactory epithelial cells, donor2	11934-125I8	63.40	16.21	3.47	2.46	0.87	0.29	0.87	0.43
Olfactory epithelial cells, donor3	11935-125I9	52.78	12.94	3.29	2.27	1.02	0.00	1.70	0.11
Olfactory epithelial cells, donor4	11936-126A1	71.10	7.89	2.73	1.36	0.39	0.00	0.49	0.00
Oligodendrocyte - precursors, donor1	11496-119F2	69.81	9.03	1.81	4.81	0.00	0.00	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	42.33	1.70	0.85	2.13	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	38.87	1.14	2.29	3.43	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	23.59	4.34	0.62	1.24	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	9.58	0.98	0.78	0.39	0.20	0.00	0.00	0.00
Osteoblast, donor2	11354-117H4	33.01	2.11	0.00	1.40	0.70	2.11	0.00	0.70
Osteoblast, donor3	11426-118G4	19.37	0.71	0.71	1.60	0.18	0.00	0.36	0.00
Pancreatic stromal cells, donor1	11249-116E7	77.92	6.32	4.97	2.11	0.59	0.00	0.51	0.08
Pericytes, donor1	11491-119E6	18.14	0.56	0.33	0.67	0.22	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	16.30	0.91	0.00	1.13	0.45	0.00	0.00	0.23
Pericytes, donor3	11652-122E5	8.34	1.83	0.41	0.00	0.20	0.00	0.41	0.00
Perineurial Cells, donor1	11499-119F5	61.14	9.27	1.47	4.52	0.68	0.23	0.11	0.11
Perineurial Cells, donor2	11579-120F4	50.42	4.14	4.23	1.75	0.09	0.00	0.09	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	480.98	21.36	8.92	5.10	4.46	6.06	0.32	3.19
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	251.23	32.57	5.63	3.92	4.41	4.90	3.67	2.20
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	372.07	18.12	6.47	4.27	3.75	2.46	0.91	1.42
Placental Epithelial Cells, donor1	11278-116H9	20.33	3.11	0.24	0.72	0.24	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	49.90	4.44	2.22	1.11	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	39.66	3.73	1.77	0.98	0.59	0.00	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	11.39	1.27	0.95	0.95	0.32	0.00	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	35.45	3.94	2.06	1.50	0.38	0.19	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	74.01	7.05	4.44	3.65	0.65	0.52	0.39	0.26
Preadipocyte - breast, donor2	11328-117E5	34.67	3.38	1.35	1.13	0.90	0.45	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	48.48	4.90	2.56	1.28	0.43	0.11	0.00	0.21
Preadipocyte - omental, donor2	11329-117E6	37.54	4.36	0.87	2.62	0.44	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	33.81	5.16	2.72	1.29	0.43	0.14	0.57	0.00
Preadipocyte - perirenal, donor1	11469-119C2	12.80	0.00	0.98	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	6.14	0.31	0.00	0.00	0.00	0.00	0.00	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	16.47	3.36	0.53	0.71	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	23.33	2.55	1.36	0.68	0.17	0.17	0.34	0.00
Preadipocyte - visceral, donor1	11280-116I2	37.63	4.75	1.77	0.37	0.65	0.19	0.09	0.19
Preadipocyte - visceral, donor2	11357-117H7	14.27	3.68	0.46	1.84	0.46	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	13.17	1.67	0.00	0.42	0.21	0.00	0.52	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	67.73	2.26	0.75	4.07	0.45	0.15	0.00	0.60
Prostate Epithelial Cells, donor2	11331-117E8	50.92	5.69	1.08	3.11	0.27	0.00	0.41	0.14
Prostate Epithelial Cells, donor3	11404-118D9	46.91	7.23	2.88	1.16	4.04	0.06	0.49	0.12
Prostate Stromal Cells, donor1	11254-116F3	30.41	2.73	0.91	2.16	0.00	0.23	0.68	0.11
Prostate Stromal Cells, donor2	11332-117E9	44.29	6.99	0.72	3.94	0.36	0.00	0.72	0.00
Prostate Stromal Cells, donor3	11405-118E1	57.04	10.53	1.46	5.01	0.73	0.00	1.46	0.00
Renal Cortical Epithelial Cells, donor1	11516-119H4	8.03	0.73	0.73	0.00	0.36	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	23.84	4.02	2.63	0.42	0.42	0.00	0.07	0.00
Renal Epithelial Cells, donor1	11517-119H5	4.57	0.51	0.51	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	4.98	0.00	1.42	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	32.08	3.39	2.22	0.21	0.74	0.00	0.11	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	5.12	0.27	0.00	0.13	0.00	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	23.31	4.22	1.78	1.78	0.00	0.00	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	4.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	10.34	0.88	0.00	0.22	0.00	0.00	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	5.64	0.00	0.63	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	2.77	0.55	0.00	0.28	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	4.03	0.27	0.54	0.27	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	3.37	0.84	0.42	0.00	0.42	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	5.40	0.96	0.77	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	51.34	5.19	2.07	1.30	0.26	0.00	0.78	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	25.01	2.56	0.85	1.99	0.00	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	5.15	2.06	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	55.20	7.28	1.76	0.25	0.50	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	223.31	18.44	6.41	7.88	0.53	0.13	0.13	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	21.44	1.79	0.89	0.89	0.00	0.00	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	34.67	2.75	3.30	0.00	1.10	0.55	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	55.69	1.16	4.64	1.16	0.00	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	33.29	1.30	0.00	0.78	0.26	0.13	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	17.78	2.58	0.60	0.70	0.30	0.20	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	30.45	4.02	2.01	1.34	0.22	0.67	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	29.65	1.24	0.50	2.11	0.12	0.50	0.00	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	18.88	1.28	1.40	0.58	0.23	0.12	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	28.89	4.39	0.69	0.92	0.69	0.92	0.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	19.17	1.37	0.00	0.82	0.27	0.00	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	21.18	1.21	0.91	1.36	0.00	0.15	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	24.19	3.05	0.54	1.43	0.18	0.36	0.18	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	19.94	1.15	0.14	1.29	0.14	0.29	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	18.24	2.04	0.54	0.32	0.11	0.21	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	20.80	3.10	0.66	0.89	0.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	18.54	1.34	0.00	0.38	0.19	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	22.08	2.33	0.75	0.93	0.09	0.19	0.09	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	36.27	2.07	0.94	0.75	0.19	0.00	0.00	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	22.69	0.80	0.27	1.19	0.27	0.00	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	25.21	2.43	1.36	1.56	0.00	0.00	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	28.26	3.63	0.76	0.38	0.00	0.38	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	19.65	0.96	0.00	0.96	0.21	0.32	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	16.54	3.36	0.84	1.40	1.12	0.00	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	24.95	2.73	1.03	1.54	0.68	0.00	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	20.42	0.73	0.36	1.09	0.36	0.36	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	19.99	3.19	0.74	0.98	0.12	0.12	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	25.25	1.48	0.67	2.01	0.27	0.40	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	14.15	2.12	0.00	0.71	0.47	0.24	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	19.64	3.57	0.99	1.19	0.60	0.00	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	20.34	3.74	0.23	1.40	0.23	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	12.23	1.87	0.00	0.83	0.21	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	21.24	1.77	0.44	0.66	0.22	0.00	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	23.19	2.72	0.42	1.46	0.21	0.42	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	15.61	1.48	0.27	0.54	0.27	0.13	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	21.46	1.53	1.70	0.68	0.51	0.17	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	18.12	2.31	2.31	1.93	0.58	0.19	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	14.27	1.38	0.34	0.34	0.17	0.34	0.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	14.27	2.19	0.41	0.69	0.14	0.41	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	22.82	2.79	0.49	1.48	0.16	0.16	0.00	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	17.72	1.36	0.00	0.85	0.00	0.00	0.34	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	24.12	2.52	1.33	1.04	0.00	0.15	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	21.06	3.47	0.80	1.60	0.53	0.53	0.00	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	31.25	1.11	0.28	0.83	0.28	0.14	0.28	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	30.24	3.57	0.71	1.19	0.00	0.00	0.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	34.46	3.83	1.81	2.02	0.20	0.00	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	26.84	1.88	0.66	1.32	0.19	0.09	0.19	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	39.83	3.49	2.10	0.70	0.35	0.70	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	42.31	5.14	4.23	2.12	0.30	0.00	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	18.24	1.47	0.12	1.10	0.24	0.12	0.12	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	84.27	4.66	3.06	2.33	0.73	1.60	0.15	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	35.90	3.65	2.43	0.61	0.00	0.00	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	17.78	2.71	0.00	0.60	0.30	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	27.37	2.26	1.81	0.68	1.13	0.68	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	39.24	3.00	3.00	0.60	0.90	0.60	0.00	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	35.54	1.53	0.00	0.94	0.12	0.35	0.00	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	32.87	2.35	0.21	0.43	0.00	0.00	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	33.65	3.00	1.20	1.80	0.60	0.00	1.20	0.60
Schwann Cells, donor1	11498-119F4	6.21	0.38	0.00	0.56	0.00	0.00	0.00	0.00
Schwann Cells, donor2	11578-120F3	20.41	3.40	0.00	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	16.43	5.48	1.31	1.75	0.66	0.00	0.66	0.00
Sebocyte, donor1	11220-116B5	58.06	3.83	2.19	2.74	0.00	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	54.23	4.14	2.76	2.30	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	17.52	1.86	0.62	1.65	0.21	0.00	0.00	0.00
Sertoli Cells, donor1	11255-116F4	67.92	13.25	0.00	4.97	0.00	0.00	1.66	0.00
Sertoli Cells, donor2	11333-117F1	53.66	5.65	0.00	2.82	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	33.17	4.84	2.02	0.53	0.35	0.44	0.09	0.44
Skeletal Muscle Cells, donor2	11358-117H8	8.67	2.17	0.00	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	7.52	1.67	0.00	0.00	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	34.09	4.24	0.94	0.94	0.31	0.16	0.47	0.31
Skeletal Muscle Cells, donor5	11455-119A6	31.81	5.20	0.30	0.74	0.15	0.00	0.59	0.15
Skeletal Muscle Cells, donor6	11459-119B1	23.55	2.77	0.31	0.31	0.31	0.00	0.31	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	57.21	5.54	4.91	1.76	1.01	0.38	0.25	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	44.23	6.71	3.42	1.00	1.28	0.00	0.71	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	31.75	4.37	3.08	0.60	0.40	0.00	0.40	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	58.22	5.14	1.77	1.01	0.25	0.42	0.25	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	5.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	12.66	1.24	0.00	0.14	0.14	0.00	0.00	0.00
Skin - palm, donor1	10286-104F7	821.95	18.80	16.12	16.12	8.06	0.00	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	28.54	2.45	0.86	1.01	0.29	0.00	0.14	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	116.14	0.82	1.64	3.27	1.64	0.82	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	25.45	2.34	0.65	2.08	0.39	0.00	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	127.05	12.09	2.78	4.87	1.67	0.14	1.81	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	73.56	10.55	2.53	3.52	0.42	0.70	0.14	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	164.50	11.00	5.92	9.52	1.27	0.21	0.42	0.21
Small Airway Epithelial Cells, donor3	11406-118E2	109.13	11.32	2.32	4.42	1.12	0.30	0.45	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	16.35	2.16	0.00	0.31	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	46.69	2.67	0.22	2.00	0.44	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	11.17	2.35	0.00	0.59	0.59	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	12.82	1.33	1.33	0.88	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	8.27	1.18	0.00	0.39	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	12.36	0.00	0.77	0.77	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	59.04	10.01	2.00	3.00	0.00	0.00	4.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	19.96	1.73	1.20	1.33	0.13	0.00	0.00	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	29.26	6.87	2.22	0.89	0.66	0.00	0.66	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	18.31	0.90	0.26	1.02	0.38	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	109.07	9.44	0.65	6.51	0.33	0.00	0.98	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	63.49	7.68	2.07	5.02	0.00	0.00	0.89	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	33.60	3.99	1.99	1.85	0.28	0.14	0.43	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	3.74	0.16	0.00	0.33	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	40.19	2.74	1.83	2.44	0.00	0.00	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	22.98	0.76	1.52	0.00	0.51	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	4.77	0.00	0.00	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	42.91	5.16	1.92	2.95	0.74	0.29	0.15	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	36.59	5.17	1.51	1.08	0.00	0.00	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	28.44	3.78	1.78	0.73	0.21	0.10	0.52	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	10.98	0.93	0.93	0.62	0.15	0.00	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	17.25	3.23	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	9.56	1.79	0.00	0.00	0.30	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	7.85	0.00	0.68	0.68	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	97.61	11.78	4.16	5.03	0.31	0.00	0.24	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	112.42	8.45	2.31	5.94	1.41	0.10	0.20	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	23.67	4.78	0.46	1.14	0.23	0.00	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	9.66	1.21	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	23.84	1.85	1.32	2.38	0.00	0.00	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	42.21	2.26	0.27	2.53	0.53	0.00	0.27	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	53.47	7.76	1.38	4.88	0.25	0.00	0.38	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	38.81	3.80	2.03	0.76	0.51	0.00	0.25	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	32.87	1.51	1.81	1.81	0.60	0.00	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.00	2.25	0.75	2.25	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	3.88	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	14.42	0.93	1.86	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.67	2.52	1.01	1.51	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	14.10	1.88	0.00	0.94	0.31	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	8.55	0.88	0.00	0.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	41.07	3.67	2.25	2.00	0.75	0.00	0.17	0.08
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	67.27	12.61	3.27	1.87	0.00	0.00	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	8.64	0.58	0.86	0.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	13.26	1.78	0.76	1.02	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	6.21	0.56	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	27.39	3.77	2.52	0.98	0.70	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	52.37	7.62	2.43	2.01	0.59	0.08	0.59	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.86	0.48	0.95	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	10.03	0.73	0.73	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	26.07	4.64	0.00	0.66	0.44	0.00	0.00	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	19.90	3.80	0.88	0.59	0.00	0.29	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	42.37	3.50	2.53	0.58	0.39	0.00	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	36.76	2.64	1.59	0.26	0.00	0.00	0.79	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	101.91	11.53	1.12	5.58	1.12	0.37	1.86	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	74.02	6.83	0.36	1.80	0.36	0.00	0.72	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	23.85	1.42	0.28	1.70	0.57	0.00	0.28	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	22.06	3.94	1.58	0.79	0.00	0.00	0.79	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	60.69	4.06	1.52	1.78	0.51	0.00	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	58.70	11.58	2.80	2.40	0.00	0.00	1.60	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	48.49	11.70	0.84	1.67	0.42	0.00	2.09	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	60.05	12.38	1.38	1.38	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	46.62	6.23	1.35	1.35	0.67	0.00	0.34	0.00
Synoviocyte, donor2	11368-117I9	84.15	15.59	4.36	5.03	0.67	0.00	1.01	0.17
Synoviocyte, donor3	11440-118H9	81.54	7.15	1.12	1.79	1.56	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	10.01	0.71	0.36	0.71	0.00	0.00	0.00	0.36
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	6.02	0.93	0.00	1.16	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	27.67	3.23	1.29	1.29	0.36	0.07	0.00	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	11.21	2.71	0.00	1.55	0.39	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	234.12	18.95	6.77	7.26	1.48	0.12	0.37	0.49
Urethra, donor2	10319-105A4	208.62	17.98	1.80	3.60	0.00	0.00	0.00	1.80
Urothelial Cells, donor1	11520-119H8	9.83	1.33	0.27	0.53	0.00	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	18.83	3.61	0.40	0.80	0.80	0.00	0.00	0.00
Urothelial Cells, donor3	11681-122H7	18.57	1.60	0.46	0.69	0.46	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	78.46	8.47	6.24	1.11	0.45	0.00	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	311.42	13.35	1.78	4.45	7.12	1.78	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	295.93	20.01	0.00	1.43	11.44	1.43	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	169.76	21.22	5.48	2.05	1.37	1.37	1.37	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	237.94	20.32	11.36	3.44	4.82	2.07	1.72	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	228.34	24.98	6.97	2.91	3.49	0.00	3.49	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	304.04	14.58	3.12	1.04	0.00	0.00	1.04	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	274.42	11.93	0.00	2.75	1.84	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	160.67	26.47	6.39	2.74	4.56	0.00	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	38.49	6.41	2.71	3.58	0.49	0.00	0.25	0.00
Wilms' tumor cell line:HFWT	10597-108E3	16.72	3.52	0.88	0.88	0.00	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	119.55	22.35	7.54	3.07	2.51	0.00	0.84	0.28
achilles tendon, donor2	10292-104G4	132.26	12.40	8.27	2.07	0.00	0.00	6.20	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	326.85	49.21	1.78	13.26	0.76	5.35	3.57	2.29
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	64.78	5.34	2.79	0.93	0.70	0.46	0.46	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	100.78	10.33	9.85	1.31	1.42	0.83	0.47	1.07
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	22.31	3.27	2.99	0.27	0.27	0.00	0.54	1.63
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	88.54	13.77	3.37	1.41	0.84	0.00	1.41	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	119.91	4.65	12.27	2.75	2.11	0.00	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	81.39	12.25	2.45	1.91	0.27	0.82	1.09	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	247.20	37.45	7.93	8.37	3.53	4.85	4.85	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	89.84	14.70	3.27	0.82	0.82	0.41	1.23	3.27
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	44.65	9.71	3.88	1.16	0.00	0.00	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	43.06	7.91	3.13	0.37	0.74	2.21	0.37	2.39
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	101.41	3.90	11.70	0.00	0.00	7.80	3.90	7.80
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	61.81	8.60	6.97	1.39	0.93	0.46	1.16	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	66.54	10.61	6.73	1.04	0.52	0.26	1.04	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	94.39	19.58	7.01	2.05	0.88	0.58	1.17	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	106.89	15.80	3.25	3.72	0.46	0.46	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	137.36	15.63	2.88	1.65	1.23	0.00	2.06	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	53.72	3.68	3.07	3.07	0.61	0.31	0.00	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	85.77	5.55	7.25	0.43	2.13	1.28	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	130.11	9.71	9.71	1.82	3.64	1.21	0.30	2.12
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	112.89	5.05	5.30	5.05	2.65	2.65	0.00	1.68
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	60.36	9.58	1.78	1.11	2.00	1.34	0.67	2.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	164.77	18.01	3.00	6.34	2.00	0.33	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	440.39	29.73	13.01	9.29	7.43	0.00	0.00	1.86
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	318.28	49.72	3.01	8.66	1.51	0.75	1.13	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	73.27	6.11	5.67	0.87	1.74	0.44	0.44	2.62
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	448.00	71.23	1.87	9.37	1.87	0.00	3.75	0.00
adenocarcinoma cell line:IM95m	10796-110I4	33.21	6.36	4.71	1.65	0.94	0.00	0.71	0.24
adipose tissue, adult, pool1	10010-101C1	121.77	3.26	3.41	2.02	0.78	0.78	0.31	0.78
adipose, donor1	10184-103D4	177.10	39.88	12.90	7.04	0.59	0.00	4.10	4.69
adipose, donor2	10185-103D5	39.74	15.41	1.22	1.22	0.81	0.00	1.62	0.00
adipose, donor3	10186-103D6	61.81	19.60	1.91	3.00	0.54	0.27	1.91	0.54
adipose, donor4	10187-103D7	23.40	32.94	5.20	0.87	0.87	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	30.77	6.00	11.05	0.32	2.21	0.00	0.32	0.00
adrenal gland, adult, pool1	10081-102A9	21.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	78.04	7.60	5.87	1.60	1.20	0.40	0.13	0.67
alveolar cell carcinoma cell line:SW 1573	10708-109H6	21.44	8.58	3.93	1.79	0.36	0.00	0.71	0.00
amniotic membrane cells, donor1	12235-129G3	143.98	14.14	7.65	2.55	9.97	0.00	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	190.01	18.60	11.83	3.72	1.35	0.00	1.69	0.00
amniotic membrane cells, donor3	12237-129G5	168.81	14.73	3.54	3.24	22.10	0.00	1.18	0.00
amygdala - adult, donor10196	10167-103B5	64.03	7.11	3.56	2.37	1.19	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	102.80	14.19	13.99	1.62	0.41	0.00	0.81	0.00
amygdala, newborn, donor10223	10360-105E9	38.73	6.78	2.26	0.32	0.00	1.29	0.97	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	54.88	3.95	3.44	0.89	1.02	0.00	0.00	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	30.45	6.84	3.31	0.44	0.66	0.00	0.44	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	274.24	46.10	2.67	21.38	0.33	0.33	4.34	0.00
aorta, adult, pool1	10052-101G7	78.26	6.86	2.35	3.33	0.00	0.00	0.39	0.20
appendix, adult	10189-103D9	233.26	16.30	5.82	3.49	4.66	0.00	0.39	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	54.69	9.63	2.75	4.13	0.34	0.00	0.69	0.00
artery, adult	10190-103E1	38.04	6.79	2.72	1.36	0.00	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	68.09	6.08	3.04	3.77	0.72	0.14	0.29	0.29
b cell line:RPMI1788	10427-106D4	187.21	15.76	5.65	4.16	0.30	1.19	0.45	0.89
basal cell carcinoma cell line:TE 354.T	10702-109G9	30.80	3.88	1.11	1.66	0.83	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	33.94	2.48	2.88	1.19	1.59	0.00	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	26.11	5.02	0.50	0.00	2.01	0.00	0.33	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	104.02	17.34	3.91	2.24	1.68	0.00	1.12	0.56
bladder, adult, pool1	10011-101C2	123.53	5.43	4.24	2.61	0.87	0.33	0.22	0.33
blood, adult, pool1	10053-101G8	75.30	37.65	6.64	0.00	0.00	0.00	2.21	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	53.09	9.42	1.71	1.71	0.86	0.00	0.00	0.00
bone marrow, adult	10192-103E3	176.13	8.10	2.02	4.05	0.67	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	20.50	6.15	4.10	0.00	0.00	0.00	0.00	1.03
brain, adult, pool1	10012-101C3	65.37	5.12	7.46	1.45	1.00	0.00	0.11	0.00
brain, fetal, pool1	10085-102B4	29.39	2.67	8.01	2.67	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	217.71	27.75	3.96	12.22	1.65	0.00	1.98	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	287.72	21.72	4.74	21.34	0.25	1.25	0.37	0.12
breast, adult, donor1	10080-102A8	60.61	2.53	3.79	1.26	0.63	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	35.70	7.62	2.54	1.02	1.02	0.00	0.51	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	35.87	6.80	3.40	1.55	1.24	0.00	0.93	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	36.14	3.45	4.14	0.69	0.23	0.00	0.00	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	98.29	19.61	1.69	6.29	1.21	0.48	1.69	0.24
carcinoid cell line:NCI-H1770	10703-109H1	43.26	8.46	0.94	0.94	0.00	0.00	0.94	0.94
carcinoid cell line:NCI-H727	10735-110B6	82.69	4.70	2.08	6.67	1.20	0.00	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	54.51	13.94	2.22	0.32	0.63	0.32	1.90	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	57.49	6.65	2.93	1.86	0.00	0.27	0.00	0.27
caudate nucleus - adult, donor10196	10177-103C6	70.23	5.76	8.06	0.00	2.30	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	100.06	11.04	9.37	1.84	5.69	0.50	0.33	0.33
caudate nucleus, adult, donor10258	10379-105H1	41.26	7.64	3.06	0.00	6.11	0.76	1.53	0.00
caudate nucleus, newborn, donor10223	10354-105E3	31.86	5.86	2.56	0.73	5.86	0.73	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	119.44	5.83	29.13	0.00	0.00	0.00	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	208.60	8.75	46.33	3.84	0.21	0.00	0.21	0.21
cerebellum, adult, pool1	10083-102B2	45.88	8.97	5.86	1.38	0.34	0.00	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	142.81	9.13	15.78	1.66	0.00	0.83	0.83	0.00
cerebral meninges, adult	10188-103D8	71.61	5.04	6.30	3.78	1.51	0.00	0.50	0.25
cerebrospinal fluid, donor2	10294-104G6	71.63	10.23	0.73	1.46	0.00	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	292.17	42.13	7.33	14.81	1.15	12.80	1.29	1.29
cervical cancer cell line:ME-180	10553-107I4	182.79	17.07	3.65	5.47	1.33	0.66	1.49	0.17
cervix, adult, pool1	10013-101C4	208.83	13.23	10.92	4.51	1.89	0.31	0.42	0.94
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	38.04	5.71	2.09	1.25	0.56	0.14	0.42	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	45.72	6.53	0.00	1.31	1.31	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	106.50	5.10	3.98	3.98	0.25	0.00	0.50	0.12
choriocarcinoma cell line:SCH	10785-110H2	69.61	12.07	3.57	1.97	0.37	0.00	1.36	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	25.85	4.51	3.32	1.19	1.42	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	140.75	13.11	4.84	5.70	1.42	0.00	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	44.55	3.18	2.59	1.79	0.10	0.00	0.00	0.00
chorionic membrane cells, donor3	12240-129G8	175.29	10.44	1.65	6.59	0.00	0.00	2.75	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	31.30	8.08	1.01	1.01	3.03	0.00	0.00	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	68.20	12.10	2.11	2.88	0.77	0.19	0.96	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	334.52	38.22	7.81	8.45	0.63	1.06	2.75	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	33.13	2.57	3.08	0.77	0.77	0.00	0.51	0.51
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	40.88	3.39	2.18	1.45	0.97	0.00	0.00	1.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	47.44	2.24	2.65	0.61	0.20	0.20	0.00	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	25.32	2.36	1.77	0.29	0.29	0.00	0.59	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	427.43	17.46	7.04	8.34	2.61	1.56	0.00	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	15.54	4.80	3.89	0.69	0.23	0.00	0.91	0.00
clear cell carcinoma cell line:TEN	10636-108I6	40.25	3.12	2.26	2.08	0.87	0.00	0.00	0.00
colon carcinoma cell line:CACO-2	10513-107D9	51.25	7.69	1.83	1.65	0.92	0.18	0.37	0.18
colon carcinoma cell line:COLO-320	10420-106C6	125.05	5.70	10.64	1.90	0.76	0.00	0.38	0.38
colon, adult, donor1	10082-102B1	149.94	20.23	2.38	10.71	3.57	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	459.20	31.02	5.29	11.63	2.70	0.35	0.59	2.00
colon, fetal, donor1	10070-101I7	357.20	88.37	4.94	14.21	3.71	0.62	6.80	4.33
common myeloid progenitor CMP, donor1	12130-128D6	458.35	4.58	22.92	41.25	4.58	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	375.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	426.63	31.45	1.27	9.77	0.00	9.77	2.12	2.12
cord blood derived cell line:COBL-a 24h infection	10453-106G3	333.41	25.51	4.08	7.40	0.15	5.28	1.81	2.41
cord blood derived cell line:COBL-a untreated	10449-106F8	344.77	28.77	1.83	9.87	0.85	8.88	1.27	1.83
corpus callosum, adult, pool1	10042-101F6	112.11	3.98	7.85	3.10	0.33	0.44	0.00	0.22
cruciate ligament, donor2	10295-104G7	143.45	4.05	7.29	3.24	0.00	0.00	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	44.94	8.83	4.82	1.61	0.00	0.00	0.80	0.00
diencephalon, adult	10193-103E4	65.76	11.28	4.56	2.64	1.44	0.00	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	85.64	16.76	1.61	5.28	1.15	0.69	0.46	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	93.34	7.95	2.56	1.03	2.56	0.00	0.51	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	59.46	6.02	2.65	2.65	1.20	0.00	0.48	0.48
ductus deferens, adult	10196-103E7	601.00	58.31	7.48	6.48	1.50	0.50	4.98	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	180.03	48.97	8.64	8.64	5.76	0.00	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	297.20	41.20	2.21	20.60	3.68	1.47	2.94	1.47
dura mater, adult, donor1	10041-101F5	161.71	6.19	5.86	5.45	1.16	1.32	0.00	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	48.86	4.66	0.00	5.55	0.89	0.67	0.44	1.11
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	63.48	6.45	0.86	6.02	0.29	0.14	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	28.98	4.32	3.70	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	21.80	3.94	2.72	0.61	0.30	0.00	0.61	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	39.83	3.40	4.63	0.00	0.62	0.00	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	53.85	9.19	3.94	2.63	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	75.42	11.73	5.36	2.01	0.00	0.00	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	48.75	6.71	8.34	1.09	0.91	0.18	0.54	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	70.92	10.45	2.09	3.06	0.48	0.00	0.80	0.00
epidermoid carcinoma cell line:A431	10426-106D3	83.04	10.23	4.34	1.45	2.22	0.00	0.22	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	76.66	5.94	3.96	2.75	0.44	0.00	0.00	0.22
epididymis, adult	10197-103E8	167.87	12.14	6.49	2.09	0.84	0.21	0.21	2.09
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	47.37	8.16	4.79	3.19	0.53	0.53	0.18	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	36.18	2.36	1.18	1.18	0.00	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	105.10	19.79	8.13	11.14	0.13	1.44	0.92	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	149.30	18.21	10.92	12.60	0.39	3.15	1.57	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	92.54	16.13	7.95	7.95	0.00	2.02	0.67	0.00
esophagus, adult, pool1	10015-101C6	228.18	13.59	5.42	5.52	3.29	0.53	0.42	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	97.68	3.01	3.38	5.13	0.25	0.38	0.00	0.13
eye - muscle inferior rectus, donor1	10272-104E2	142.46	19.32	4.83	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	73.65	6.31	2.10	4.21	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	66.97	5.95	2.98	1.49	1.49	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	85.99	8.03	3.44	0.00	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	192.38	7.29	4.37	2.91	2.91	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	188.64	20.59	8.14	4.32	1.27	1.02	1.78	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	42.44	7.05	3.46	1.41	1.03	0.38	0.38	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	36.09	10.21	2.85	0.95	1.19	0.24	0.24	0.95
frontal lobe, adult, pool1	10040-101F4	77.87	4.41	8.91	2.25	0.66	0.09	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	129.71	14.11	3.30	4.80	0.30	0.00	0.30	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	39.13	2.65	3.57	0.73	0.37	0.09	0.18	0.09
gall bladder, adult	10198-103E9	106.71	7.48	1.69	2.66	1.69	0.00	0.48	0.00
gamma delta positive T cells, donor1	11937-126A2	404.79	49.39	9.13	5.37	0.54	1.61	4.83	0.54
gamma delta positive T cells, donor2	11938-126A3	270.78	27.64	8.59	2.61	1.87	1.49	2.61	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	67.17	5.49	0.63	2.32	0.21	0.00	1.06	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	53.96	3.67	1.55	2.13	1.16	0.58	0.58	0.00
gastric cancer cell line:AZ521	10549-107H9	63.12	9.35	4.75	1.80	1.31	1.31	0.00	0.98
gastric cancer cell line:GSS	10560-108A2	31.12	5.49	3.66	0.00	1.83	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	157.86	18.28	1.83	8.00	2.51	0.46	0.91	0.23
giant cell carcinoma cell line:LU65	10487-107B1	33.73	5.97	0.80	0.69	1.15	0.80	0.11	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	55.70	4.90	2.66	1.26	0.98	0.28	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	141.67	28.43	8.48	5.24	2.49	0.25	2.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	28.08	2.74	2.01	0.63	0.74	0.00	0.32	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	32.16	3.93	5.20	0.98	0.00	0.00	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	35.65	3.97	1.88	2.10	0.11	0.00	0.11	0.00
glioma cell line:GI-1	10413-106B8	30.75	1.46	2.64	0.59	0.29	0.29	0.00	0.29
globus pallidus - adult, donor10196	10175-103C4	58.31	6.56	3.64	0.73	2.92	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	113.02	12.69	13.43	1.95	1.71	0.00	0.24	0.98
globus pallidus, adult, donor10258	10367-105F7	62.98	6.85	0.00	4.11	1.37	0.00	2.74	0.00
globus pallidus, newborn, donor10223	10364-105F4	34.11	4.26	2.13	0.53	1.07	0.00	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	281.42	12.24	36.71	7.34	0.00	2.45	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	65.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	83.63	0.00	5.23	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	22.72	4.80	1.60	1.60	0.64	0.00	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	25.71	3.21	1.38	1.84	0.46	0.00	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	21.03	5.94	0.00	2.74	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	16.75	2.58	0.64	1.29	0.00	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	17.25	1.44	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	13.72	3.43	0.00	0.69	0.00	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	54.07	9.93	1.10	4.41	1.10	0.00	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	178.73	29.88	2.01	6.61	0.29	1.44	3.45	0.57
heart - mitral valve, adult	10205-103F7	79.82	6.28	2.99	2.39	0.90	0.30	0.30	0.60
heart - pulmonic valve, adult	10206-103F8	103.02	8.89	5.49	3.14	0.52	0.26	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	69.11	19.15	0.00	2.50	0.00	0.00	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	45.50	7.14	4.69	3.67	0.20	0.20	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	56.64	3.83	0.43	4.26	0.00	0.43	0.00	0.00
heart, adult, pool1	10016-101C7	50.82	4.60	2.07	0.23	0.00	0.00	0.00	0.00
heart, fetal, pool1	10046-101G1	113.15	3.39	4.21	2.26	0.21	0.31	0.00	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	25.61	5.55	2.16	0.93	0.31	0.00	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	162.92	7.14	1.19	9.51	3.57	0.00	2.38	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	38.67	6.74	1.66	4.75	0.77	0.22	0.00	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	42.12	4.25	2.06	5.95	0.24	0.24	0.12	0.24
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	46.59	5.56	1.72	4.65	0.81	0.51	0.20	0.10
hepatoma cell line:Li-7	10484-107A7	117.11	13.79	0.56	8.34	0.00	1.33	0.56	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	89.45	9.55	3.22	5.23	0.40	0.70	0.70	1.41
hippocampus - adult, donor10196	10169-103B7	61.51	8.52	7.57	2.84	0.00	0.00	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	104.09	9.80	15.31	2.04	0.41	0.00	0.82	0.00
hippocampus, adult, donor10258	10374-105G5	55.27	4.48	1.49	0.50	0.50	0.50	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	28.20	4.58	3.17	0.70	0.35	0.35	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	32.96	9.16	4.27	3.05	1.22	0.00	1.22	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	21.21	3.93	1.18	0.59	0.20	0.00	0.39	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	19.30	3.55	2.03	1.27	0.25	0.00	0.51	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	66.54	12.41	3.38	3.38	0.56	0.00	2.82	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	55.52	11.88	3.36	2.84	0.77	0.00	1.29	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	74.02	8.73	4.93	2.66	1.14	0.00	1.14	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	104.81	7.01	4.67	6.42	0.88	0.00	0.58	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	85.31	8.40	6.68	5.17	0.43	0.22	0.22	3.02
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	92.17	8.34	3.75	2.50	0.42	0.42	1.67	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	85.96	9.95	3.55	3.32	0.71	0.71	0.24	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	59.79	10.93	2.73	3.86	0.96	0.48	0.32	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	76.08	6.06	4.04	2.69	0.67	0.67	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	14.87	5.48	2.03	1.10	0.31	0.00	0.94	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	27.02	3.44	0.49	1.47	0.00	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	29.67	6.98	1.75	0.87	0.87	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	71.40	13.36	5.15	1.91	1.34	0.00	0.57	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	59.74	10.47	1.74	1.31	0.44	0.00	0.87	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	91.96	13.49	5.00	2.50	0.00	0.00	3.00	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	47.47	6.59	4.90	1.51	0.57	0.00	0.38	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	50.93	3.64	2.27	1.36	0.00	0.45	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	57.01	8.46	7.83	2.51	1.25	0.00	2.51	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	59.61	11.76	3.76	3.10	1.14	0.33	0.82	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	61.55	9.58	0.58	3.19	0.87	0.29	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	73.54	9.57	6.28	1.79	0.00	0.30	1.20	0.60
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	20.51	4.80	2.03	0.18	0.00	0.00	0.37	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	18.26	3.99	0.57	0.57	0.00	0.00	0.00	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	33.07	4.90	1.63	1.22	1.22	0.00	2.04	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	48.59	6.34	1.06	2.82	0.70	0.35	0.35	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	47.51	7.60	2.22	1.90	0.63	0.00	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	53.56	8.17	4.24	0.61	0.30	0.00	0.91	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	56.88	2.59	3.62	2.07	0.52	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	56.45	5.98	3.98	1.99	0.66	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	62.59	3.33	5.39	1.80	1.28	0.00	0.77	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	49.85	3.83	2.05	2.05	0.51	0.51	1.02	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	59.06	11.36	0.76	2.27	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	50.07	10.42	4.03	1.01	0.67	0.67	0.67	1.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	19.56	3.62	1.45	1.21	0.24	0.00	0.00	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	25.40	5.35	2.23	0.89	1.34	0.00	2.23	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	21.46	5.85	2.93	0.98	0.00	0.00	1.46	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	58.68	6.42	3.97	3.36	0.31	0.00	0.61	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	377.38	35.79	35.79	0.00	0.00	0.00	9.76	13.01
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	74.79	12.24	6.95	2.65	0.66	0.00	1.32	1.65
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	77.72	8.76	3.28	3.83	0.00	0.00	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	77.44	9.05	5.07	2.90	0.36	0.00	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	71.89	6.41	6.05	2.49	0.00	0.00	1.42	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	44.16	8.35	1.19	2.39	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	87.76	5.28	3.52	2.71	0.41	0.81	0.14	1.08
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	51.72	11.31	2.42	2.69	0.27	0.27	1.62	0.27
immature langerhans cells, donor1	11904-125F5	49.64	2.42	2.91	0.48	1.70	0.73	0.24	0.00
immature langerhans cells, donor2	11905-125F6	61.79	8.71	1.58	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	74.29	3.12	6.62	2.46	0.57	0.19	0.00	0.28
keratoacanthoma cell line:HKA-1	10791-110H8	129.08	31.21	5.20	3.58	1.95	0.33	2.28	0.00
kidney, adult, pool1	10017-101C8	55.67	2.40	4.31	1.20	0.70	0.00	0.20	0.10
kidney, fetal, pool1	10045-101F9	81.49	1.77	5.59	1.63	0.99	0.07	0.00	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	91.18	10.79	7.10	2.13	1.56	0.00	0.14	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	43.41	6.77	1.11	2.35	0.69	0.41	0.69	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	56.70	7.71	4.04	1.47	0.37	0.00	0.92	0.18
left atrium, adult, donor1	10079-102A7	38.68	2.72	0.00	0.00	1.09	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	45.00	6.07	1.52	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	17.51	4.65	1.64	1.09	0.55	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	35.92	6.47	0.72	3.95	0.36	0.00	1.44	0.00
leiomyoma cell line:15242A	10570-108B3	22.83	3.26	0.00	1.09	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	38.12	9.96	0.73	2.67	0.24	0.00	0.73	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	76.19	0.00	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	80.51	7.32	3.14	0.00	0.00	0.00	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	132.93	10.27	3.31	6.97	0.59	2.36	1.65	0.47
liposarcoma cell line:KMLS-1	10782-110G8	36.08	2.66	3.12	2.34	0.47	0.47	0.31	0.47
liposarcoma cell line:SW 872	10726-110A6	30.70	5.00	2.92	1.83	0.24	0.00	0.49	0.24
liver, adult, pool1	10018-101C9	204.85	9.72	3.40	7.78	0.32	1.13	0.16	1.30
liver, fetal, pool1	10086-102B5	52.68	11.29	0.00	1.88	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	54.83	6.12	4.81	1.46	0.87	0.00	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	88.95	9.60	9.78	3.14	0.92	0.00	0.74	0.00
locus coeruleus, adult, donor10258	10375-105G6	31.04	6.21	1.97	0.85	0.00	0.00	0.85	0.00
locus coeruleus, newborn, donor10223	10362-105F2	80.34	6.31	5.05	4.21	0.42	0.00	0.42	1.26
lung adenocarcinoma cell line:A549	10499-107C4	43.59	5.54	3.32	2.21	1.25	0.55	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	54.46	3.45	7.58	5.52	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	43.63	4.09	3.43	1.19	1.05	0.00	0.13	0.00
lung, adult, pool1	10019-101D1	107.14	3.78	5.67	0.71	0.83	0.24	0.24	0.83
lung, fetal, donor1	10068-101I5	327.36	7.71	2.00	6.85	1.14	0.00	0.00	1.43
lung, right lower lobe, adult, donor1	10075-102A3	67.82	12.83	3.67	4.12	0.92	0.00	0.46	2.29
lymph node, adult, donor1	10077-102A5	93.25	9.94	5.21	2.37	0.95	0.47	0.95	0.47
lymphangiectasia cell line:DS-1	10727-110A7	88.11	17.75	3.73	1.97	0.66	0.00	0.88	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	91.01	6.79	2.11	3.62	0.75	1.36	0.60	1.36
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	180.09	22.09	7.65	1.70	0.85	0.85	1.70	1.70
mature adipocyte, donor1	12231-129F8	110.55	5.77	4.44	2.22	1.33	0.00	0.44	0.89
mature adipocyte, donor2	12232-129F9	90.48	4.77	4.57	0.62	0.62	0.42	0.21	0.62
mature adipocyte, donor3	12233-129G1	91.51	3.56	4.74	3.56	0.47	0.24	0.71	1.19
mature adipocyte, donor4	12234-129G2	137.40	5.79	10.27	3.95	0.53	0.26	0.79	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	86.96	6.19	5.96	4.53	3.10	0.95	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	59.79	12.41	2.26	2.26	1.13	0.00	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	91.03	6.80	12.69	0.92	1.29	0.18	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	43.84	9.53	3.49	2.54	0.32	0.00	0.32	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	53.74	4.69	4.69	0.85	1.28	0.85	0.85	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	54.84	2.70	9.45	1.35	0.17	0.00	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	101.87	10.40	15.07	1.91	0.85	0.00	1.06	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	40.45	3.85	0.00	1.93	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	387.55	14.35	114.83	14.35	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	29.43	1.44	3.59	0.72	0.00	0.00	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	74.63	11.68	3.89	1.30	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	108.52	6.35	12.54	2.48	0.00	0.00	0.93	0.15
medulla oblongata, adult, pool1	10038-101F2	75.99	3.10	4.24	2.69	0.49	0.16	0.08	0.16
medulla oblongata, newborn, donor10223	10361-105F1	54.51	10.07	4.17	1.39	0.00	0.00	0.69	0.69
medulloblastoma cell line:D283 Med	10838-111E1	126.65	7.97	4.65	2.66	0.89	0.22	1.11	0.22
medulloblastoma cell line:ONS-76	10759-110E3	15.16	0.98	1.35	0.61	0.00	0.12	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	46.29	5.89	1.29	1.15	0.29	1.15	0.14	0.29
melanoma cell line:G-361	10465-106H6	53.48	5.70	2.17	1.90	1.09	0.27	0.00	1.63
meningioma cell line:HKBMM	10691-109F7	35.10	6.33	1.81	0.54	0.18	0.00	0.36	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	127.77	14.98	7.05	4.41	0.00	0.00	1.76	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	39.14	1.56	2.85	0.52	0.00	0.00	0.52	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.60	1.99	1.23	1.84	0.46	0.00	0.15	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	24.72	1.64	0.73	0.73	0.00	0.18	0.00	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	44.31	2.07	0.41	1.24	0.00	0.41	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	47.90	2.39	0.14	1.69	0.14	0.00	0.14	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	40.05	2.70	0.19	1.93	0.58	0.19	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	74.96	10.41	4.86	3.47	0.00	0.00	2.08	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.63	2.06	0.17	0.34	0.17	0.00	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	30.59	1.61	0.35	1.15	0.23	0.12	0.12	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	23.48	1.99	0.13	0.40	0.00	0.00	0.27	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.83	2.43	0.41	0.81	0.27	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	22.19	1.42	0.43	1.42	0.57	0.00	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	19.76	1.98	1.98	0.99	0.33	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	22.83	0.28	0.83	0.83	0.42	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	22.34	3.14	1.40	1.05	0.00	0.00	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	27.56	3.47	0.41	0.82	0.20	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.18	2.88	0.72	0.72	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	20.38	1.03	0.93	0.41	0.52	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	26.22	5.93	1.60	0.68	0.00	0.00	0.68	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	33.56	3.36	0.84	2.10	0.42	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	21.82	1.05	0.00	0.90	0.00	0.15	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	35.54	1.75	0.26	1.66	0.09	0.00	0.18	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	29.82	1.47	1.10	0.74	0.74	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	13.74	1.14	0.57	0.29	0.29	0.29	0.00	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	59.36	7.58	1.26	2.11	0.84	0.00	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	22.38	3.20	1.83	0.91	0.91	0.00	0.46	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	28.65	4.60	1.79	1.53	0.26	0.26	0.00	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	30.36	3.93	3.14	1.05	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.04	5.55	2.46	1.23	0.92	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	28.01	3.29	1.41	1.18	0.00	0.00	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	30.46	7.78	2.03	1.35	0.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	24.76	3.14	1.57	0.79	0.79	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	28.27	4.17	2.32	0.46	0.93	0.00	0.93	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	35.76	3.75	3.75	0.58	0.00	0.29	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	29.23	3.79	2.01	1.12	0.22	0.45	0.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	32.21	6.49	1.44	1.20	0.48	0.00	0.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	42.53	2.93	1.47	1.47	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	25.17	4.03	1.01	0.34	0.00	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	28.25	4.09	1.64	0.41	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	31.36	1.72	4.30	0.86	0.43	0.00	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	32.81	2.73	5.47	0.00	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	30.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	28.91	3.57	1.95	0.00	0.65	0.00	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	13.09	5.82	1.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	26.12	4.80	1.07	1.60	0.00	0.00	2.13	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	20.44	4.09	0.00	1.64	0.00	0.82	1.64	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	20.99	1.94	1.55	0.00	0.39	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	12.59	2.10	2.10	2.10	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	22.85	6.95	0.99	0.99	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	42.90	4.77	4.77	0.00	0.00	0.00	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	19.57	4.74	0.59	0.59	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	23.15	1.22	1.22	0.00	0.00	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	23.44	3.80	0.63	0.63	1.90	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	28.63	3.45	3.10	1.38	0.34	0.00	1.03	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	30.09	4.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	23.95	11.98	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	61.99	10.33	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.97	2.85	0.41	0.41	0.41	0.00	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	24.63	6.36	1.59	1.59	0.79	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	17.69	4.13	0.00	0.00	0.00	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	25.56	7.48	0.62	1.25	0.31	0.00	1.25	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	6.68	1.34	0.00	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	56.77	11.83	1.18	0.00	1.18	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	53.93	12.84	0.00	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	50.94	11.01	0.69	2.07	0.00	0.00	1.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	60.37	9.90	1.48	1.98	0.00	0.49	1.48	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	41.50	8.97	2.24	4.49	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	45.16	7.63	1.91	1.91	0.00	1.27	2.54	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	39.90	14.10	1.21	2.82	0.00	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	32.71	8.72	2.18	2.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	35.48	5.07	0.00	0.00	1.27	1.27	1.27	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	59.47	6.68	1.82	4.25	0.00	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	54.23	22.59	4.52	4.52	4.52	0.00	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	52.72	23.06	2.47	1.65	0.00	0.82	2.47	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	35.92	6.15	0.79	0.99	0.60	0.79	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	31.80	10.06	1.30	0.65	0.32	0.00	1.30	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	34.63	5.09	3.06	3.06	0.00	0.00	4.07	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	75.82	3.09	3.87	3.09	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	23.86	5.43	2.83	1.18	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	47.96	8.57	2.09	1.85	0.23	0.00	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	38.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	49.53	1.13	1.23	1.34	0.21	0.00	0.00	0.21
mesothelioma cell line:Mero-25	10850-111F4	12.71	2.04	0.23	0.68	0.00	0.00	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	7.58	1.47	0.73	0.00	0.49	0.00	0.24	0.00
mesothelioma cell line:Mero-48a	10852-111F6	16.83	2.88	0.89	0.00	0.44	0.00	0.44	0.00
mesothelioma cell line:Mero-82	10853-111F7	32.85	6.04	1.84	1.31	0.26	0.00	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	24.85	4.26	1.02	0.34	0.34	0.00	0.51	0.00
mesothelioma cell line:Mero-84	10855-111F9	6.82	1.01	0.76	0.25	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	25.26	4.97	1.86	1.04	0.21	0.00	0.62	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	21.53	4.64	1.99	1.16	1.49	0.00	0.50	0.00
mesothelioma cell line:NCI-H226	10846-111E9	5.61	1.27	0.54	0.54	0.54	0.00	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	28.87	4.78	3.25	0.68	0.85	0.00	0.00	0.17
mesothelioma cell line:NCI-H28	10845-111E8	25.19	6.36	1.27	0.51	0.76	0.00	0.25	0.00
mesothelioma cell line:No36	10857-111G2	33.60	6.52	1.30	1.63	0.65	0.00	0.33	0.00
mesothelioma cell line:ONE58	10858-111G3	21.68	5.69	0.27	0.54	0.27	0.00	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	32.43	0.77	3.07	0.58	0.96	0.00	0.00	0.58
migratory langerhans cells, donor2	11902-125F3	26.74	0.61	1.59	0.61	0.49	0.12	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	23.15	1.26	1.79	0.36	0.90	0.00	0.18	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	30.04	8.49	1.96	1.31	0.00	0.00	0.65	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	34.76	7.42	1.27	0.64	0.00	0.00	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	69.57	8.52	7.60	1.38	3.46	0.00	0.23	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	267.17	41.86	3.81	7.99	0.19	4.19	4.38	1.33
myelodysplastic syndrome cell line:SKM-1	10772-110F7	182.39	25.87	5.91	5.54	4.07	1.48	1.29	3.14
myeloma cell line:PCM6	10474-106I6	118.80	19.37	4.74	1.38	1.38	1.38	1.58	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	90.80	9.13	2.03	2.03	0.00	0.00	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	13.14	1.18	0.20	0.20	0.20	0.00	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	32.54	3.90	1.11	1.34	4.57	0.56	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	32.58	3.60	1.69	0.88	3.02	0.15	0.51	0.00
nasal epithelial cells, donor2	12227-129F4	71.21	14.35	1.66	2.76	1.10	0.55	1.10	0.00
neuroblastoma cell line:CHP-134	10508-107D4	61.66	7.59	6.90	1.38	0.23	0.92	0.00	1.15
neuroblastoma cell line:NB-1	10539-107G8	72.78	8.79	4.30	3.93	0.37	0.37	0.19	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	16.03	0.84	1.05	0.42	0.21	0.42	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	78.08	8.57	5.03	0.93	0.56	0.37	0.56	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	47.92	6.17	5.46	0.47	0.47	0.00	0.71	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	65.89	11.25	5.54	0.63	0.63	0.48	1.27	0.48
neuroectodermal tumor cell line:TASK1	10774-110F9	43.27	9.66	4.63	0.20	1.81	0.60	1.41	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	27.34	1.91	4.45	0.00	0.64	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	34.87	11.71	1.60	1.06	0.53	0.00	0.27	0.00
neutrophil PMN, donor1	12133-128D9	461.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	146.09	0.00	0.00	0.00	0.00	13.28	0.00	0.00
neutrophil PMN, donor3	12141-128E8	123.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	141.89	7.78	22.15	0.85	0.51	0.17	0.17	1.18
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	26.42	0.80	0.80	0.80	0.80	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	41.04	11.54	3.85	2.89	0.64	0.00	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	45.72	8.41	1.31	3.42	0.53	0.00	1.31	0.00
nucleus accumbens, adult, pool1	10037-101F1	88.96	3.47	7.59	1.97	1.97	0.28	0.00	0.19
occipital cortex - adult, donor10196	10172-103C1	53.57	2.06	6.18	4.12	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	98.49	15.57	16.10	2.95	0.81	0.00	0.81	0.00
occipital cortex, newborn, donor10223	10355-105E4	32.39	0.73	4.00	0.00	0.73	0.36	0.00	0.36
occipital lobe, adult, donor1	10076-102A4	39.62	4.99	2.10	0.52	0.26	0.00	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	34.33	5.58	4.72	0.00	1.72	0.00	0.43	0.00
occipital pole, adult, pool1	10036-101E9	46.20	1.34	4.34	1.10	0.00	0.00	0.00	0.00
olfactory region, adult	10195-103E6	57.89	5.16	6.11	1.53	0.57	0.38	0.00	0.00
optic nerve, donor1	10277-104E7	110.06	16.01	0.00	8.00	0.00	0.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	76.77	5.35	1.71	2.39	0.23	0.68	0.23	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	76.11	6.18	3.43	1.65	0.14	0.14	0.14	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	56.72	7.11	3.05	0.85	1.02	0.00	0.17	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	42.85	5.20	2.19	1.16	0.46	0.00	0.23	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	73.20	11.76	1.18	1.76	1.18	0.00	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	72.88	3.74	4.67	1.87	3.74	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	116.00	9.54	1.70	3.82	0.42	0.64	0.42	0.21
ovary, adult, pool1	10020-101D2	183.61	6.64	3.76	4.45	0.96	0.17	0.09	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	19.25	4.77	0.73	0.92	0.18	0.18	0.55	0.18
pancreas, adult, donor1	10049-101G4	437.40	79.01	1.88	22.58	4.70	0.00	8.47	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	76.31	17.33	1.68	3.35	0.56	0.00	1.68	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	41.91	5.28	2.04	1.53	0.68	0.00	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	47.52	4.14	7.62	0.66	0.83	0.00	0.50	0.00
paracentral gyrus, adult, pool1	10035-101E8	63.52	3.66	7.32	2.11	0.37	0.00	0.00	0.09
parietal cortex, adult, donor10258	10373-105G4	45.51	3.67	0.73	2.20	3.67	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	41.38	13.17	4.70	0.00	0.94	0.00	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	85.23	9.12	12.54	1.43	0.00	0.00	0.00	0.57
parietal lobe, adult, pool1	10034-101E7	61.07	1.67	7.05	0.88	0.53	0.09	0.18	0.00
parietal lobe, fetal, donor1	10072-101I9	36.85	8.73	6.79	0.97	1.94	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	34.02	4.49	5.23	0.37	0.37	0.37	0.37	0.37
parotid gland, adult	10199-103F1	862.71	92.50	3.08	57.97	3.70	0.00	4.32	0.00
penis, adult	10200-103F2	136.43	17.72	1.07	3.76	3.22	0.00	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	36.82	4.65	2.97	0.56	0.56	0.00	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	49.24	9.76	2.77	3.35	0.29	0.15	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	101.27	9.03	10.32	2.58	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	227.41	19.54	22.50	4.15	1.18	0.00	1.18	1.18
pineal gland, adult, donor10258	10377-105G8	88.42	5.64	7.52	1.88	0.63	0.00	0.63	0.63
pituitary gland - adult, donor10196	10180-103C9	324.79	20.24	12.14	16.19	1.01	2.02	1.01	1.01
pituitary gland, adult, donor10252	10162-103A9	514.40	20.33	14.59	23.45	3.13	2.61	0.52	1.56
pituitary gland, adult, donor10258	10378-105G9	148.97	17.88	11.92	6.81	1.70	0.00	1.70	0.85
placenta, adult, pool1	10021-101D3	404.53	22.79	10.64	13.87	0.65	0.11	0.86	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	270.02	26.88	2.38	9.80	0.53	2.52	2.38	1.59
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	35.95	4.51	3.74	1.09	0.47	0.00	0.16	0.00
pons, adult, pool1	10033-101E6	74.88	3.27	4.99	2.84	0.43	0.17	0.00	0.26
postcentral gyrus, adult, pool1	10032-101E5	52.48	2.96	6.63	1.57	0.26	0.00	0.17	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	357.63	0.00	18.82	18.82	2.09	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	154.23	5.51	0.00	0.00	0.00	5.51	0.00	5.51
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	11.74	0.00	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	46.17	11.22	7.28	1.02	0.29	0.00	0.73	0.29
prostate cancer cell line:PC-3	10439-106E7	54.45	7.62	2.72	1.45	0.36	0.00	0.36	0.18
prostate, adult, pool1	10022-101D4	167.14	7.26	5.62	4.26	1.00	0.00	0.00	0.45
putamen, adult, donor10196	10176-103C5	78.85	8.26	10.86	0.71	5.19	0.94	0.24	0.47
putamen, adult, donor10252	10152-102I8	94.11	9.80	13.73	0.00	5.88	1.96	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	30.60	2.19	0.00	0.00	3.28	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	50.50	3.62	3.87	0.72	7.01	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	37.48	3.00	2.25	0.75	1.50	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	102.70	13.96	6.11	2.62	1.75	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	121.02	19.47	9.74	5.56	1.39	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	17.60	1.27	1.70	0.21	0.42	0.00	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	60.89	10.36	7.87	0.83	0.41	0.00	0.83	0.00
retina, adult, pool1	10030-101E3	179.71	6.36	6.86	4.27	1.59	0.50	0.30	0.30
retinoblastoma cell line:Y79	10475-106I7	89.11	18.19	16.37	2.86	1.30	0.00	0.52	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	26.31	3.69	1.11	1.72	0.12	0.12	0.49	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	66.36	5.91	2.81	1.69	0.28	0.56	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	93.22	3.79	1.52	4.55	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	390.72	32.21	1.62	30.27	1.46	1.62	1.62	0.32
salivary acinar cells, donor2	11772-123I8	576.36	55.76	3.30	30.98	1.24	2.07	2.75	1.79
salivary acinar cells, donor3	11773-123I9	952.69	64.22	6.62	23.83	6.62	2.65	1.32	0.66
salivary gland, adult, pool1	10093-102C3	742.97	40.61	0.57	58.34	2.29	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	66.02	6.24	2.61	1.10	0.17	0.67	0.17	0.42
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	66.53	5.29	3.29	1.65	0.24	0.12	0.59	0.47
seminal vesicle, adult	10201-103F3	572.46	77.77	7.94	10.05	1.06	1.06	8.47	2.12
serous adenocarcinoma cell line:JHOS-2	10639-108I9	44.70	6.32	1.70	2.92	0.24	0.00	1.21	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	20.38	1.76	1.26	0.25	0.50	0.00	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	13.05	0.00	0.00	0.00	0.00	0.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	18.80	2.28	1.34	0.27	0.27	0.00	0.54	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	29.73	2.76	2.10	0.88	0.55	0.11	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	14.84	3.10	0.90	0.52	1.29	0.00	0.26	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	52.49	2.84	2.84	1.42	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	41.98	1.80	3.48	0.36	0.36	0.24	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	34.17	7.04	1.01	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	271.41	54.28	13.57	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	171.69	27.77	10.10	5.05	0.00	0.00	4.42	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	31.35	4.67	2.00	3.00	0.33	0.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	96.45	9.46	5.99	4.41	0.95	0.00	0.63	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	42.02	9.83	10.41	2.89	1.54	0.39	0.77	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	121.81	6.26	3.96	11.70	1.32	0.66	0.49	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	179.99	17.69	9.17	3.70	1.45	0.16	1.29	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	53.39	4.14	1.96	4.36	0.44	0.22	0.44	0.00
small intestine, adult, pool1	10024-101D6	506.92	31.53	9.79	10.03	6.09	0.96	1.07	1.79
small intestine, fetal, donor1	10064-101I1	107.12	18.67	5.16	4.18	4.18	0.49	0.00	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	39.49	8.21	1.03	1.03	2.56	0.00	1.54	0.51
smooth muscle, adult, pool1	10048-101G3	100.02	9.82	3.10	4.39	0.26	0.26	0.52	0.00
somatostatinoma cell line:QGP-1	10781-110G7	90.86	10.72	5.63	5.90	4.02	1.07	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	71.80	2.52	5.05	1.61	0.69	0.69	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	100.54	7.49	7.10	1.97	0.00	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	71.95	7.61	1.38	0.69	0.00	0.69	3.46	0.00
spinal cord, fetal, donor1	10056-101H2	78.67	10.37	7.93	3.66	0.00	0.00	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	76.23	3.67	4.59	1.38	0.46	0.46	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	43.61	5.82	2.39	1.19	0.60	0.00	1.05	0.00
spleen, adult, pool1	10025-101D7	201.22	9.14	7.82	1.98	0.44	0.99	0.22	0.88
spleen, fetal, pool1	10044-101F8	129.99	3.10	6.91	2.07	1.03	0.40	0.00	0.24
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	262.92	20.60	7.04	9.63	1.76	2.17	0.83	1.45
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	63.42	11.39	2.85	0.57	0.19	0.19	0.57	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	70.24	8.39	7.34	3.49	0.35	0.00	1.05	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	32.06	7.43	1.17	1.17	0.00	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	22.85	4.95	2.14	0.56	1.01	0.00	0.23	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	13.13	2.97	0.85	0.00	0.85	0.00	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	42.73	3.81	3.38	1.27	0.00	0.00	0.42	0.00
stomach, fetal, donor1	10062-101H8	535.05	71.55	7.48	23.50	1.07	0.00	1.07	0.00
submaxillary gland, adult	10202-103F4	623.80	63.23	1.71	35.32	2.28	0.57	0.57	1.14
substantia nigra - adult, donor10196	10178-103C7	271.37	651.29	0.00	0.00	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	83.71	10.80	8.93	2.08	0.62	0.00	0.42	0.21
substantia nigra, adult, donor10258	10371-105G2	64.66	7.24	0.52	3.10	1.03	0.00	1.03	0.00
substantia nigra, newborn, donor10223	10358-105E7	48.05	11.31	2.83	0.00	0.00	0.00	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	29.58	5.50	2.06	2.52	0.92	0.00	0.46	0.23
temporal lobe, adult, pool1	10031-101E4	46.37	1.86	5.85	0.59	0.25	0.08	0.08	0.25
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	42.74	6.41	3.56	0.00	0.71	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	47.91	8.35	3.96	1.32	0.00	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	62.49	12.57	3.84	2.09	0.35	0.00	0.70	0.00
tenocyte, donor2	11765-123I1	84.31	16.40	3.82	1.91	0.00	0.00	1.53	0.00
tenocyte, donor3	11768-123I4	92.30	23.72	2.22	3.71	1.11	0.00	1.11	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	8.33	2.89	0.51	0.85	0.17	0.00	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	55.96	8.02	2.77	2.93	0.31	0.00	0.62	0.00
teratocarcinoma cell line:PA-1	10807-111A6	17.51	4.03	0.62	1.70	0.62	0.15	0.31	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	49.38	9.77	1.52	2.67	0.25	0.00	1.02	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	61.64	4.92	4.16	1.51	0.00	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	152.47	7.96	0.65	4.69	1.09	0.00	0.33	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	173.60	24.43	7.82	5.86	1.30	0.00	1.63	0.33
testis, adult, pool1	10026-101D8	146.46	6.98	8.48	3.01	1.29	0.11	0.21	0.86
testis, adult, pool2	10096-102C6	111.42	12.63	7.22	5.41	1.35	0.00	0.90	0.00
thalamus - adult, donor10196	10168-103B6	73.97	8.83	5.52	3.31	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	107.21	6.88	11.56	2.19	0.78	0.00	0.31	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	1.54	3.08	1.54	1.54	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	28.00	2.47	2.80	0.99	0.99	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	29.34	7.48	1.73	1.15	0.58	0.00	0.58	0.58
throat, adult	10209-103G2	197.49	15.23	3.50	6.49	1.50	0.75	1.50	0.00
throat, fetal, donor1	10061-101H7	216.34	24.68	7.31	15.84	1.52	0.30	0.61	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	35.18	4.97	2.98	0.40	0.79	0.00	0.00	0.60
thymus, adult, pool1	10027-101D9	205.19	3.58	12.43	3.38	2.29	0.30	0.00	1.09
thymus, fetal, pool1	10043-101F7	328.44	7.79	13.72	5.09	2.18	0.83	0.52	0.94
thyroid carcinoma cell line:KHM-5M	10776-110G2	22.47	3.99	1.60	0.13	1.06	0.00	0.27	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	38.97	9.92	3.63	0.84	0.28	0.00	0.42	0.14
thyroid, adult, pool1	10028-101E1	535.80	32.66	6.53	21.28	2.99	0.56	0.84	0.47
thyroid, fetal, donor1	10060-101H6	298.73	40.08	7.38	33.49	0.79	0.53	3.95	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	314.12	33.88	12.32	6.16	3.08	0.00	6.16	0.00
tongue, adult	10203-103F5	143.27	11.40	3.72	3.72	2.56	0.23	0.47	0.23
tongue, fetal, donor1	10059-101H5	153.30	24.04	6.31	7.88	2.36	0.00	1.58	0.00
tonsil, adult, pool1	10047-101G2	294.62	10.02	5.71	6.61	2.60	0.60	0.20	0.30
trachea, adult, pool1	10029-101E2	169.98	7.69	4.34	5.97	2.29	0.25	0.08	0.25
trachea, fetal, donor1	10058-101H4	118.87	24.62	3.85	4.23	1.54	0.00	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	30.47	7.44	0.00	3.90	0.35	0.00	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	28.88	1.93	1.42	0.61	0.61	0.00	0.20	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	115.17	21.62	11.44	2.82	0.94	0.47	1.57	0.31
tridermal teratoma cell line:HGRT	10694-109G1	163.62	19.03	0.00	15.22	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	24.72	3.39	1.19	1.19	0.51	0.08	0.08	0.17
umbilical cord, fetal, donor1	10057-101H3	81.37	12.52	0.00	6.26	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	221.82	8.36	1.02	2.90	0.85	0.00	0.17	0.51
uterus, fetal, donor1	10055-101H1	168.42	23.04	11.77	1.54	3.07	0.00	0.51	0.00
vagina, adult	10204-103F6	104.68	2.58	3.23	0.00	1.94	0.00	0.00	0.00
vein, adult	10191-103E2	146.42	8.33	4.60	1.97	1.75	0.22	0.44	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	119.37	15.49	2.40	5.07	1.60	0.53	0.80	0.27